Globalstar (GSAT) 10-Q6 Nov 142014 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014	Oct. 31, 2014
	Sep. 30, 2014	Voting Common Stock	Nonvoting Common Stock
Document and Entity Information [Line Items]	'	'	'
Document type	'10-Q	'	'
Amendment flag	'false	'	'
Document period end date	30-Sep-14	'	'
Document fiscal year focus	'2014	'	'
Document fiscal period focus	'Q3	'	'
Trading symbol	'GSAT	'	'
Entity registrant name	'Globalstar, Inc.	'	'
Entity central index key	'0001366868	'	'
Current fiscal year end date	'--12-31	'	'
Entity filer category	'Accelerated Filer	'	'
Entity common stock, shares outstanding (shares)	'	855,827,575	134,008,656

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue:	'	'	'	'
Service revenues	$18,511	$17,056	$52,647	$47,854
Subscriber equipment sales	4,930	5,493	15,324	13,863
Total revenue	23,441	22,549	67,971	61,717
Operating expenses:	'	'	'	'
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	7,868	8,181	21,926	22,913
Cost of subscriber equipment sales	3,836	4,148	11,240	10,675
Cost of subscriber equipment sales - reduction in the value of inventory	0	0	7,317	0
Marketing, general, and administrative	8,783	9,079	24,799	22,579
Depreciation, amortization, and accretion	21,047	23,715	66,393	66,114
Total operating expenses	41,534	45,123	131,675	122,281
Loss from operations	-18,093	-22,574	-63,704	-60,564
Other income (expense):	'	'	'	'
Loss on extinguishment of debt	-12,936	-63,569	-39,615	-110,809
Loss on equity issuance	0	-2,733	0	-16,701
Interest income and expense, net of amounts capitalized	-9,067	-16,901	-33,853	-39,869
Derivative gain (loss)	166,989	-97,534	-418,663	-126,911
Other	2,586	-1,540	2,207	-1,125
Total other income (expense)	147,572	-182,277	-489,924	-295,415
Income (loss) before income taxes	129,479	-204,851	-553,628	-355,979
Income tax expense	89	118	1,255	341
Net income (loss)	129,390	-204,969	-554,883	-356,320
Loss per common share:	'	'	'	'
Basic (USD per share)	$0.13	($0.30)	($0.61)	($0.64)
Diluted (USD per share)	$0.11	($0.30)	($0.61)	($0.64)
Weighted-average shares outstanding:	'	'	'	'
Basic (shares)	987,668	673,546	914,474	559,515
Diluted (shares)	1,189,190	673,546	914,474	559,515
Comprehensive income (loss)	$128,896	($204,417)	($555,754)	($356,417)

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$27,221	$17,408
Accounts receivable, net of allowance of $4,977 and $7,419, respectively	16,217	15,723
Inventory	29,277	31,817
Advances for inventory	196	9,359
Prepaid expenses and other current assets	7,456	7,059
Total current assets	80,367	81,366
Property and equipment, net	1,120,156	1,169,785
Restricted cash	37,918	37,918
Deferred financing costs	66,816	76,436
Intangible and other assets, net of accumulated amortization of $6,138 and $5,669, respectively	14,703	7,103
Total assets	1,319,960	1,372,608
Current liabilities:	'	'
Current portion of long-term debt	7,271	4,046
Accounts payable, including contractor payables of $6,580 and $7,665, respectively	12,195	14,627
Accrued contract termination charge	22,238	24,133
Accrued expenses	25,866	22,700
Payables to affiliates	443	202
Derivative liabilities	0	57,048
Deferred revenue	22,191	17,284
Total current liabilities	90,204	140,040
Long-term debt, less current portion	623,770	665,236
Employee benefit obligations	3,146	3,529
Derivative liabilities	575,803	405,478
Deferred revenue	6,787	7,079
Debt restructuring fees	20,795	20,795
Other non-current liabilities	13,987	13,696
Total non-current liabilities	1,244,288	1,115,813
Commitments and contingent liabilities (Notes 7 and 8)	'	'
Stockholdersb (deficit) equity:	'	'
Preferred Stock	'	'
Additional paid-in capital	1,499,290	1,074,837
Accumulated other comprehensive income	0	871
Retained deficit	-1,513,921	-959,038
Total stockholdersb (deficit) equity	-14,532	116,755
Total liabilities and stockholdersb (deficit) equity	1,319,960	1,372,608
Series A Preferred Stock	'	'
Stockholdersb (deficit) equity:	'	'
Preferred Stock	'	'
Common Stock	'	'
Stockholdersb (deficit) equity:	'	'
Common Stock	86	54
Nonvoting Common Stock	'	'
Stockholdersb (deficit) equity:	'	'
Common Stock	$13	$31

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Accounts receivable, allowance	$4,977	$7,419
Accumulated amortization	6,138	5,669
Accrued second-generation constellation costs	$6,580	$7,665
Preferred stock, par value (USD per share)	$0.00	$0.00
Preferred stock, shares authorized (shares)	100,000,000	100,000,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Series A Preferred Stock	'	'
Preferred stock, par value (USD per share)	$0.00	$0.00
Preferred stock, shares authorized (shares)	1	1
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common Stock	'	'
Common stock, par value (USD per share)	$0.00	$0.00
Common stock, shares authorized (shares)	1,200,000,000	1,200,000,000
Common stock, shares issued (shares)	855,827,575	535,883,461
Common stock, shares outstanding (shares)	855,827,575	535,883,461
Nonvoting Common Stock	'	'
Common stock, par value (USD per share)	$0.00	$0.00
Common stock, shares authorized (shares)	400,000,000	400,000,000
Common stock, shares issued (shares)	134,008,656	309,008,656
Common stock, shares outstanding (shares)	134,008,656	309,008,656

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows provided by (used in) operating activities:	'	'
Net loss	($554,883)	($356,320)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'
Depreciation, amortization, and accretion	66,393	66,114
Change in fair value of derivative assets and liabilities	418,663	126,067
Stock-based compensation expense	2,312	1,850
Amortization of deferred financing costs	7,591	6,256
Provision for bad debts	1,688	1,359
Reduction in the value of inventory	7,317	0
Noncash interest and accretion expense	13,511	22,341
Loss on extinguishment of debt	39,615	110,809
Loss on equity issuance	0	16,701
Discount on future shares issued to vendor	748	0
Other, net	1,426	605
Unrealized foreign currency (gain) loss	-3,017	635
Changes in operating assets and liabilities:	'	'
Accounts receivable	-2,699	-4,001
Inventory	4,403	4,253
Prepaid expenses and other current assets	-961	-1,353
Other assets	-2,028	874
Accounts payable and accrued expenses	1,317	4,617
Payables to affiliates	242	73
Other non-current liabilities	193	-996
Deferred revenue	5,044	2,450
Net cash provided by operating activities	6,875	2,334
Cash flows (provided by) used in investing activities:	'	'
Second-generation satellites, ground and related launch costs (including interest)	-3,862	-37,732
Property and equipment additions	-2,203	-1,225
Investment in business	0	-496
Restricted cash	0	8,838
Net cash used in investing activities	-6,065	-30,615
Cash flows provided by (used in) financing activities	'	'
Borrowings from Facility Agreement	0	672
Proceeds from contingent equity agreement	0	1,071
Payments to reduce principal amount of exchanged 5.75% Notes	0	-13,544
Payments for 5.75% Notes not exchanged	0	-6,250
Payments to lenders and other fees associated with exchange	0	-2,482
Proceeds from equity issuance to related party	0	51,500
Payments of deferred financing costs	-164	-16,904
Proceeds from issuance of common stock and exercise of warrants	9,303	8,979
Net cash provided by financing activities	9,139	23,042
Effect of exchange rate changes on cash	-136	90
Net increase (decrease) in cash and cash equivalents	9,813	-5,149
Cash and cash equivalents, beginning of period	17,408	11,792
Cash and cash equivalents, end of period	27,221	6,643
Supplemental disclosure of cash flow information:	'	'
Cash paid for: Interest	10,335	11,445
Cash paid for: Income taxes	95	28
Supplemental disclosure of non-cash financing and investing activities:	'	'
Increase in non-cash capitalized accrued interest for second-generation satellites and ground costs	1,237	3,691
Capitalization of the accretion of debt discount and amortization of prepaid financing costs	1,973	4,716
Payments made in convertible notes and common stock	12,910	4,240
Principal amount of debt converted into common stock	76,040	23,570
Reduction of debt discount and deferred financing costs due to conversion of debt	28,073	13,164
Increase (reduction) in accrued second-generation satellites and ground costs	1,887	-9,688
Reduction in carrying amount of Thermo Loan agreement due to amendment	0	-35,026
Fair value of common stock issued upon conversion of debt	269,826	0
Reduction in derivative liability due to conversion of debt	182,051	0
Extinguishment of principal amount of 5.75% Notes	0	-71,804
Issuance of principal amount of 8.00% Notes Issued in 2013	0	54,611
Issuance of common stock to exchanging note holders	$0	$12,127

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Parenthetical)	Sep. 30, 2014	Sep. 30, 2013	20-May-13
5.00% Convertible Senior Unsecured Notes	'	'	'
Interest rate, payable in cash	'	5.75%	'
Loan interest rate	5.00%	'	'
8.00% Convertible Senior Notes Issued in 2013	'	'	'
Interest rate, payable in cash	5.75%	'	5.75%
Loan interest rate	'	8.00%	8.00%

Basis_of_Presentation

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	BASIS OF PRESENTATION

	The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information. Certain information and footnote disclosures normally in financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission; however, management believes the disclosures made are adequate to make the information presented not misleading. These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in Globalstar, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013 and Management's Discussion and Analysis of Financial Condition and Results of Operations herein.

	The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation, the reserve for product warranties, and income taxes. Actual results could differ from these estimates.

	All significant intercompany transactions and balances have been eliminated in the consolidation. In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company’s condensed consolidated statements of operations, condensed consolidated balance sheets, and condensed consolidated statements of cash flows for the periods presented. These unaudited interim condensed consolidated financial statements include the accounts of Globalstar and its majority owned or otherwise controlled subsidiaries. The results of operations for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for the full year or any future period.

	The Company evaluates events that occur after the balance sheet date but before the financial statements are issued for potential recognition or disclosure. Based on the evaluation, the Company determined that there were no material subsequent events for recognition or disclosure other than those disclosed herein.

	Recently Issued Accounting Pronouncements

	In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. This standard requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing reporting.

Property_and_Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	PROPERTY AND EQUIPMENT

	Property and equipment consists of the following (in thousands):



		September 30,				December 31,
		2014				2013
	Globalstar System:

	Space component

	Second-generation satellites in service	$	1,212,040			$	1,212,099

	Prepaid long-lead items	17,040				17,040

	Second-generation satellite, on-ground spare	32,459				32,365

	Ground component	48,126				48,378

	Construction in progress:

	Space component	11				—

	Ground component	129,489				116,377

	Other	1,811				1,115

	Total Globalstar System	1,440,976				1,427,374

	Internally developed and purchased software	15,794				14,931

	Equipment	12,670				12,385

	Land and buildings	3,719				3,768

	Leasehold improvements	1,662				1,644

	Total property and equipment	1,474,821				1,460,102

	Accumulated depreciation	(354,665		)		(290,317		)
	Total property and equipment, net	$	1,120,156			$	1,169,785


	Amounts in the above table consist primarily of costs incurred related to the construction of the Company’s second-generation constellation and ground upgrades. Amounts included in the Company’s second-generation satellite, on-ground spare balance as of September 30, 2014 consist of costs related to a spare second-generation satellite that is capable of being included in a future launch of satellites. As of September 30, 2014, this satellite and the prepaid long-lead items have not been placed into service, and therefore the Company has not yet recorded depreciation expense for these items.

	Capitalized Interest and Depreciation Expense

	The following tables summarize capitalized interest for the periods indicated below (in thousands):



		Three Months Ended								Nine Months Ended

		September 30, 2014				September 30, 2013				September 30, 2014				September 30, 2013
	Interest cost eligible to be capitalized	$	10,508			$	13,119			$	34,123			$	38,851

	Interest cost recorded in interest expense, net	(8,557		)		(10,151		)		(28,365		)		(24,302		)
	Net interest capitalized	$	1,951			$	2,968			$	5,758			$	14,549


	The following table summarizes depreciation expense for the periods indicated below (in thousands):



	Three Months Ended								Nine Months Ended
	September 30, 2014				September 30, 2013				September 30, 2014				September 30, 2013
Depreciation Expense	$	20,653			$	23,931			$	65,040			$	65,622

LongTerm_Debt_and_Other_Financ

Long-Term Debt and Other Financing Arrangements	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Long-Term Debt and Other Financing Arrangements	'
	LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS

	Long-term debt consists of the following (in thousands):



		September 30, 2014						31-Dec-13
		Principal			Carrying			Principal			Carrying
		Amount			Value			Amount			Value
	Facility Agreement	$	586,342		$	586,342		$	586,342		$	586,342

	Thermo Loan Agreement	66,106			30,307			60,383			22,854

	8.00% Convertible Senior Notes Issued in 2013	23,032			14,392			46,971			26,291

	8.00% Convertible Senior Unsecured Notes Issued in 2009	—			—			51,652			33,795

	Total Debt	675,480			631,041			745,348			669,282

	Less: Current Portion	7,271			7,271			4,046			4,046

	Long-Term Debt	$	668,209		$	623,770		$	741,302		$	665,236


	The above table presents the principal amount and carrying value of long-term debt at September 30, 2014 and December 31, 2013. The principal amounts shown above include payment of in-kind interest as of the date paid-in-kind notes, if any, are issued. The carrying value is net of any discounts to the loan amounts at issuance, including accretion, as further described below. The amount included in the table above as the current portion of long-term debt includes the next scheduled principal repayments under the Facility Agreement, which are due in December 2014 and June 2015.

	Facility Agreement

	The Company’s senior secured credit facility agreement (“Facility Agreement”) was amended and restated in August 2013 and is scheduled to mature in December 2022. Semi-annual principal repayments are scheduled to begin in December 2014. The facility bears interest at a floating rate of LIBOR plus 2.75% through June 2017, increasing by an additional 0.5% each year thereafter to a maximum rate of LIBOR plus 5.75%. Ninety-five percent of the Company’s obligations under the Facility Agreement are guaranteed by COFACE, the French export credit agency. The Company’s obligations under the Facility Agreement are guaranteed on a senior secured basis by all of its domestic subsidiaries and are secured by a first priority lien on substantially all of the assets of the Company and its domestic subsidiaries (other than their FCC licenses), including patents and trademarks, 100% of the equity of the Company’s domestic subsidiaries and 65% of the equity of certain foreign subsidiaries.

	The Facility Agreement contains customary events of default and requires that the Company satisfy various financial and nonfinancial covenants. Pursuant to the terms of the Facility Agreement, the Company has the ability to cure noncompliance with financial covenants with equity contributions through June 2017. If the Company violates any of these financial and nonfinancial covenants and is unable to obtain waivers or avoid an event of default through an equity cure contribution, the Company would be in default under the agreement, and payment of the indebtedness could be accelerated. The acceleration of the Company’s indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-acceleration provisions. The Company was in compliance with all covenants in the Facility Agreement as of September 30, 2014.

	The Facility Agreement requires the Company to maintain a total of $37.9 million in a debt service reserve account. The use of the funds in this account is restricted to making principal and interest payments under the Facility Agreement. As of September 30, 2014, the balance in the debt service reserve account was $37.9 million and classified as restricted cash.

	Thermo Loan Agreement

	The Company has an Amended and Restated Loan Agreement (the “Loan Agreement”) with Thermo whereby Thermo agreed to lend the Company $25.0 million for the purpose of funding the debt service reserve account required under the Facility Agreement. In 2011, this loan was increased to $37.5 million. This loan is subordinated to, and the debt service reserve account is pledged to secure, all of the Company’s obligations under the Facility Agreement. Amounts deposited in the debt service reserve account are restricted to payments due under the Facility Agreement, unless otherwise authorized by the lenders.

	The loan accrues interest at 12% per annum, which is capitalized and added to the outstanding principal in lieu of cash payments. The Company will make payments to Thermo only when permitted under the Facility Agreement. The loan becomes due and payable 6 months after the obligations under the Facility Agreement have been paid in full, or earlier if the Company has a change in control or any acceleration of the maturity of the loans under the Facility Agreement occurs. As of September 30, 2014, $28.6 million of interest was accrued; this amount is included in long-term debt on the Company’s condensed consolidated balance sheet.

	The Company evaluated the various embedded derivatives within the Loan Agreement. The Company determined that the conversion option and the contingent put feature upon a fundamental change required bifurcation from the Loan Agreement. The conversion option and the contingent put feature were not deemed clearly and closely related to the Loan Agreement and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the Loan Agreement.

	The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the maturity of the Loan Agreement using an effective interest rate method. The fair value of the compound embedded derivative liability is marked-to-market at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices.

	8.00% Convertible Senior Notes Issued in 2013

	On May 20, 2013, the Company entered into an Exchange Agreement with the beneficial owners and investment managers for beneficial owners (the “Exchanging Note Holders”) of approximately 91.5% of its outstanding 5.75% Convertible Senior Notes (“5.75% Notes”) and completed the transactions contemplated by the Exchange Agreement. Pursuant to the Exchange Agreement, the Company issued $54.6 million aggregate principal amount of 8.00% Convertible Senior Notes (the “8.00% Notes Issued in 2013”) to the Exchanging Note Holders. The 8.00% Notes Issued in 2013 are convertible into shares of common stock at an initial conversion price of $0.80 per share of common stock, or 1,250 shares of the Company’s common stock per $1,000 principal amount of the 8.00% Notes Issued in 2013, subject to adjustment as provided in the Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as Trustee (the “New Indenture”). As a result of the exchange and redemption, the Company recognized a loss on extinguishment of debt of approximately $47.2 million in the second quarter of 2013, representing the difference between the old 5.75% Notes and the fair value of the consideration given in the exchange. The conversion price of the 8.00% Notes Issued in 2013 will be adjusted in the event of certain stock splits or extraordinary share distributions, or as a reset of the base conversion and exercise price pursuant to the terms of the New Indenture. Due to common stock issuances by the Company since May 20, 2013 at prices below the then effective conversion rate, the base conversion rate had been reduced to $0.73 per share of common stock as of September 30, 2014.

	The 8.00% Notes Issued in 2013 are senior unsecured debt obligations of the Company, with no sinking fund. The 8.00% Notes Issued in 2013 will mature on April 1, 2028, subject to various call and put features, and bear interest at a rate of 8.00% per annum. Interest on the 8.00% Notes Issued in 2013 is payable semi-annually in arrears on April 1 and October 1 of each year. Interest is paid in cash at a rate of 5.75% per annum and additional notes at a rate of 2.25% per annum. The New Indenture provides for customary events of default. As of September 30, 2014, the Company was not in default under the New Indenture with respect to the 8.00% Notes Issued in 2013.

	Subject to certain conditions set forth in the New Indenture, the Company may redeem the 8.00% Notes Issued in 2013, with the prior approval of the Majority Lenders, in whole or in part, at any time on or after April 1, 2018, at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be redeemed plus all accrued and unpaid interest thereon.

	A holder of 8.00% Notes Issued in 2013 has the right, at the Holder’s option, to require the Company to purchase some or all of the 8.00% Notes Issued in 2013 held by it on each of April 1, 2018 and April 1, 2023 at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be purchased plus accrued and unpaid interest.

	Subject to the procedures for conversion and other terms and conditions of the New Indenture, a holder may convert its 8.00% Notes Issued in 2013 at its option at any time prior to the close of business on the business day immediately preceding April 1, 2028, into shares of common stock (or, at the option of the Company, cash in lieu of all or a portion thereof, provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders).

	A holder was permitted to elect to convert up to 15% of its 8.00% Notes Issued in 2013 on each of July 19, 2013 and March 20, 2014. If a holder had elected to convert on either of those dates, it would have received, at the Company’s option, either cash equal to the par value of the 8.00% Notes Issued in 2013 plus accrued interest (provided that, under the Facility Agreement, the Company could pay cash only with the consent of the Majority Lenders) or shares of the Company’s common stock equal to the principal amount of the 8.00% Notes Issued in 2013 to be converted plus accrued interest divided by the lower of the average price of the common stock in a specified period and $0.50. On July 19, 2013, $7.0 million principal amount (approximately 12.9% of the outstanding principal amount) of 8.00% Notes Issued in 2013 were converted, resulting in the issuance of 14.3 million shares of common stock. On March 20, 2014, $7.0 million principal amount (approximately 15.0% of the outstanding principal amount) of 8.00% Notes Issued in 2013 were converted, resulting in the issuance of an additional 14.6 million shares. Through September 30, 2014, a total of $32.4 million principal amount of 8.00% Notes Issued in 2013 had been converted, resulting in the issuance of approximately 59.5 million shares of voting common stock relating to the special conversions discussed above as well as normal conversions pursuant to the terms of the New Indenture. The Company recorded a loss on extinguishment of debt of approximately $43.8 million during the nine months ended September 30, 2014 related to these conversions. Pursuant to the terms in the New Indenture for the 8.00% Notes Issued in 2013 for normal conversions, holders receive conversion shares over a 40-consecutive trading day settlement period. As a result of this feature, the portion of converted debt is extinguished on an incremental basis over the 40-day settlement period, reducing the Company's debt balance outstanding. As of September 30, 2014, there were no conversions that had been initiated, but not yet fully settled.

	The Company evaluated the various embedded derivatives within the New Indenture. The Company determined that the conversion option and the contingent put feature within the New Indenture required bifurcation from the 8.00% Notes Issued in 2013. The conversion option and the contingent put feature were not deemed clearly and closely related to the 8.00% Notes Issued in 2013 and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the 8.00% Notes Issued in 2013.

	The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the first put date of the 8.00% Notes Issued in 2013 (April 1, 2018) using an effective interest rate method. The fair value of the compound embedded derivative liability is being marked-to-market at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices.

	8.00% Convertible Senior Notes Issued in 2009

In June 2009, the Company sold $55.0 million in aggregate principal amount of 8.00% Notes Issued in 2009 and Warrants (the “8.00% Warrants”) to purchase 15.3 million shares of the Company’s common stock. The 8.00% Notes Issued in 2009 were subordinated to all of the Company’s obligations under the Facility Agreement. The 8.00% Notes Issued in 2009 were the Company’s senior unsecured debt obligations and, except as described in the preceding sentence, ranked pari passu with its existing unsecured, unsubordinated obligations, including its 8.00% Notes Issued in 2013. The 8.00% Notes Issued in 2009 were scheduled to mature at the later of the tenth anniversary of closing (June 19, 2019) or six months following the maturity date of the Facility Agreement and bore interest at a rate of 8.00% per annum. Interest on the 8.00% Notes Issued in 2009 was payable in the form of additional notes or, subject to certain restrictions, in common stock at the option of the holder. Interest was payable semi-annually in arrears on June 15 and December 15 of each year.

The 8.00% Warrants contained full ratchet anti-dilution protection, and the exercise price of the Warrants was subject to adjustment under certain circumstances. In the event of certain transactions that involve a change of control, the holders of the 8.00% Warrants maintained the right to make the Company purchase the warrants for cash, subject to certain conditions. The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 19, 2014. As a result of the expiration of this period on June 19, 2014, all outstanding 8.00% Warrants were exercised during the second quarter of 2014, resulting in the issuance of 38.2 million shares of Globalstar common stock. Holders of the 8.00% Warrants had the right to exercise on either a cash or cashless basis. The Company received approximately $7.5 million in cash as a result of these exercises.

Pursuant to the terms of the indenture governing the 8.00% Notes Issued in 2009, if at any time the closing price of the common stock were to exceed 200% of the conversion price of the 8.00% Notes Issued in 2009 for 30 consecutive trading days, all of the outstanding 8.00% Notes Issued in 2009 would be automatically converted into common stock. The condition for the automatic conversion was met on April 15, 2014, and all outstanding 8.00% Notes Issued in 2009 (approximately $37.8 million principal amount at that time) converted on that date into approximately 34.5 million shares of the Company’s voting common stock.

Prior to expiration of the 8.00% Warrants and the automatic conversion of the 8.00% Notes Issued in 2009, the exercise price of the 8.00% Warrants was $0.32, and the base conversion price of the 8.00% Notes Issued in 2009 was $1.14.




The Company initially accreted the debt discount associated with the compound embedded derivative liability to interest expense over the outstanding term of the 8.00% Notes Issued in 2009 using an effective interest rate method. Upon the automatic conversion of the 8.00% Notes Issued in 2009, the remaining debt discount was written off through extinguishment gain (loss). The Company recorded a gain on extinguishment of debt of approximately $4.3 million during the nine months ended September 30, 2014 related to these conversions.

Warrants Outstanding

As a result of the Company’s financing arrangements described above, as of September 30, 2014 and December 31, 2013, warrants were outstanding to purchase 45.1 million and 93.5 million shares, respectively, of the Company’s common stock as shown in the table below:



	Outstanding Warrants					Strike Price
	September 30,			December 31,		September 30,			December 31,
	2014			2013		2014			2013
Contingent Equity Agreement (1)	37,088,418			41,467,980		$	0.01		$	0.01

Thermo Loan Agreement (2)	—			4,205,608		—			0.01

5.0% Notes (3)	8,000,000			8,000,000		0.32			0.32

8.00% Notes Issued in 2009 (4)	—			39,842,813		—			0.32

	45,088,418			93,516,401



-1	Pursuant to the terms of the Contingent Equity Agreement, the Company has issued to Thermo warrants to purchase shares of common stock pursuant to the annual availability fee and subsequent reset provisions in the Contingent Equity Agreement. These warrants have a five-year exercise period from issuance. These warrants were issued between June 2009 and June 2012, and the exercise periods expire between June 2014 and June 2017. As of September 30, 2014, Thermo had exercised warrants to purchase approximately 4.4 million of these shares prior to the expiration of the associated warrants.

-2	As consideration for the Loan Agreement with Thermo, the Company issued Thermo warrants to purchase shares of common stock. The exercise period of the warrants issued in connection with the Thermo Loan Agreement was five years from issuance, which expired in June 2014. Thermo exercised all of these warrants in the second quarter of 2014.

-3	The 5.0% Warrants are exercisable until June 2016, which is five years after their issuance.

-4	The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014. All 8.00% Warrants were exercised in the second quarter of 2014.

Consent Agreement and Common Stock Purchase (and Option) Agreement

As discussed above, on May 20, 2013, the Company exchanged its 5.75% Notes for the 8.00% Notes Issued in 2013. In connection with this exchange, the Company and Thermo entered into various financial arrangements as described below.

The Consent Agreement

On May 20, 2013, the Company entered into the Equity Commitment, Restructuring Support and Consent Agreement dated as of May 20, 2013 among Globalstar, Thermo, BNP Paribas, as agent, and the lenders under the Facility Agreement (the “Consent Agreement”) and the Global Deed of Amendment and Restatement (the “GARA”) with Thermo. To obtain the lenders’ consent to the transactions contemplated by the Exchange Agreement, pursuant to the Consent Agreement, Thermo agreed that it would make, or arrange for third parties to make, cash contributions to the Company in exchange for equity, subordinated convertible debt or other equity-linked securities as follows:


•	At the closing of the exchange transaction and thereafter each week until no later than July 31, 2013, an amount sufficient to enable the Company to maintain a consolidated unrestricted cash balance of at least $4.0 million;

•	At the closing of the exchange transaction, $25.0 million to satisfy all cash requirements associated with the exchange transaction, including agreed principal and interest payments to the holders of the 5.75% Notes as contemplated by the Exchange Agreement, with any remaining portion being retained by the Company for working capital and general corporate purposes;

•	Contemporaneously with, and as a condition to the closing of, any restructuring of the Facility Agreement, $20.0 million (less any amount contributed pursuant to the commitment described above with respect to the Company’s minimum cash balance);

•	Subject to the prior closing of the Facility Agreement restructuring, on or prior to December 26, 2013, $20.0 million; and

•	Subject to the prior closing of the Facility Agreement restructuring, on or prior to December 31, 2014, $20.0 million, less the amount by which the aggregate amount of cash received by the Company under the first, third and fourth commitments described above exceeds $40 million.

In accordance with the terms of the Common Stock Purchase Agreement and Common Stock Purchase and Option Agreement, discussed below, as of September 30, 2014, Thermo had contributed a total of $65.0 million to the Company in exchange for 171.9 million shares of the Company’s nonvoting common stock. As of September 30, 2014, Thermo had fulfilled its obligations under the agreements.

The Common Stock Purchase Agreement

On May 20, 2013, the Company and Thermo entered into a Common Stock Purchase Agreement pursuant to which Thermo purchased 78,125,000 shares of the Company’s common stock for $25.0 million ($0.32 per share). Thermo also agreed to purchase additional shares of common stock at $0.32 per share as and when required to fulfill its equity commitment described above to maintain the Company’s consolidated unrestricted cash balance at not less than $4.0 million until the earlier of July 31, 2013 and the closing of a restructuring of the Facility Agreement. In furtherance thereof, at the closing of the transactions contemplated by the Exchange Agreement, Thermo purchased an additional 15,625,000 shares of common stock for an aggregate purchase price of $5.0 million. In June 2013, Thermo purchased an additional 28,125,000 shares of common stock for an aggregate purchase price of $9.0 million pursuant to the Common Stock Purchase Agreement. Pursuant to its commitment, Thermo invested $6.0 million in July 2013 and $6.5 million in August 2013 on terms determined by a special committee of the Company's board of directors consisting solely of unaffiliated directors as described below.

During 2013, Thermo purchased in total approximately 121.9 million shares of the Company’s common stock pursuant to the Common Stock Purchase Agreement for an aggregate $39.0 million, as discussed in the previous paragraph. As a result of these transactions, during the second quarter of 2013, the Company recognized a loss on the sale of these shares of approximately $14.0 million (included in other income/expense on the condensed consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company’s common stock (measured as the closing stock price on the date of each sale). Pursuant to the Common Stock Purchase Agreement, the shares of common stock are intended to be shares of non-voting common stock. As of May 20, 2013, the Company's certificate of incorporation did not provide for any authorized but unissued shares of non-voting common stock. On July 8, 2013, the Company filed an amendment to its certificate of incorporation increasing the number of authorized shares of non-voting common stock, and the Company subsequently delivered Thermo shares of non-voting common stock for the payments previously made.

The terms of the Common Stock Purchase Agreement were approved by a special committee of the Company’s board of directors consisting solely of the Company’s unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of the Common Stock Purchase Agreement were fair and in the best interests of the Company and its shareholders.

The Common Stock Purchase and Option Agreement

On October 14, 2013, the Company and Thermo entered into a Common Stock Purchase and Option Agreement pursuant to which Thermo agreed to purchase 11,538,461 shares of the Company’s nonvoting common stock at a purchase price of $0.52 per share in exchange for $6.0 million invested in July and an additional $20 million, or 38,461,538 shares, of which $6.5 million was invested in August 2013 and the remaining $13.5 million was invested under the First Option, described below. The Common Stock Purchase and Option Agreement also granted the Company a First Option and a Second Option, as defined in the agreement, to sell to Thermo up to $13.5 million and $11.5 million, respectively, of nonvoting common stock, as and when exercised by the special committee, through November 28, 2013 and December 31, 2013, respectively. The First Option to sell up to $13.5 million in shares to Thermo was at a purchase price of $0.52 per share. The Second Option to sell up to $11.5 million in shares to Thermo was at a price equal to 85% of the average closing price of the voting common stock during the ten trading days immediately preceding the date of the special committee’s exercise of the option. In November 2013, the Company and the special committee amended the Common Stock Purchase and Option Agreement to defer the expiration date of the Second Option to March 31, 2014. The Second Option under the Common Stock Purchase and Option Agreement was not exercised and therefore has expired.

During 2013, Thermo purchased approximately 24.0 million shares of the Company’s common stock pursuant to the terms of the Common Stock Purchase and Option Agreement for an aggregate purchase price of $12.5 million. As a result of these transactions, during the third quarter of 2013, the Company recognized a loss on the sale of these shares of approximately $2.4 million (included in other income/expense on the condensed consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company’s common stock (measured as the closing stock price on the date of each sale).

In November 2013, the Company exercised the First Option, and on December 27, 2013 Thermo purchased 26.0 million shares of common stock at a purchase price of $0.52 per share for a total additional investment of $13.5 million.

The terms of the Common Stock Purchase and Option Agreement were approved by a special committee of the Company’s board of directors consisting solely of the Company’s unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of the Common Stock Purchase and Option Agreement were fair and in the best interests of the Company and its shareholders.

Terrapin Opportunity, L.P. Common Stock Purchase Agreement

On December 28, 2012 the Company entered into a Common Stock Purchase Agreement with Terrapin pursuant to which the Company may, subject to certain conditions, require Terrapin to purchase up to $30.0 million of shares of voting common stock over the 24-month term following the effectiveness of a resale registration statement, which became effective on August 2, 2013. This type of arrangement is sometimes referred to as a committed equity line financing facility. From time to time over the 24-month term following the effectiveness of the registration statement, and in the Company’s sole discretion, the Company may present Terrapin with up to 36 draw down notices requiring Terrapin to purchase a specified dollar amount of shares of voting common stock, based on the price per share per day over ten consecutive trading days (a "Draw Down Period"). The per share purchase price for these shares will equal the daily volume weighted average price of common stock on each date during the Draw Down Period on which shares are purchased, less a discount ranging from 3.5% to 8% based on a minimum price that the Company specifies. In addition, in the Company’s sole discretion, but subject to certain limitations, the Company may require Terrapin to purchase a percentage of the daily trading volume of its common stock for each trading day during the Draw Down Period. The Company has agreed not to sell to Terrapin a number of shares of voting common stock which, when aggregated with all other shares of voting common stock then beneficially owned by Terrapin and its affiliates, would result in the beneficial ownership by Terrapin or any of its affiliates of more than 9.9% of the then issued and outstanding shares of voting common stock.

When the Company makes a draw under the Terrapin equity line agreement, it will issue Terrapin shares of common stock calculated using a price per share as specified in the agreement. As of September 30, 2014, Terrapin had purchased a total of 6.1 million shares of voting common stock at a purchase price of $6.0 million pursuant to the terms of the agreement. As of September 30, 2014, $24.0 million remains available under this agreement.

Derivatives

Derivatives	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivatives	'
	DERIVATIVES

	In connection with certain borrowings disclosed in Note 3, the Company was required to record derivative instruments on its condensed consolidated balance sheets. None of these derivative instruments are designated as a hedge. The following tables disclose the fair values and classification of the derivative instruments on the Company’s condensed consolidated balance sheets (in thousands):



		September 30,			31-Dec-13
		2014
	Intangible and other assets:

	Interest rate cap	$	72		$	185

	Total intangible and other assets	$	72		$	185

	Derivative liabilities, current:

	Warrants issued with 8.00% Notes Issued in 2009	$	—		$	(57,048	)

	Derivative liabilities, non-current:

	Compound embedded derivative with 8.00% Notes Issued in 2009	$	—		$	(66,022	)

	Compound embedded derivative with 8.00% Notes Issued in 2013	(109,896		)	(109,794		)
	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(465,907		)	(229,662		)
	Total derivative liabilities, non-current:	(575,803		)	(405,478		)
	Total derivative liabilities, current and non-current	$	(575,803	)	$	(462,526	)

	The following table discloses the changes in value during the three and nine months ended September 30, 2014 and 2013 recorded as derivative gain (loss) on the Company’s condensed consolidated statement of operations (in thousands):



		Three Months Ended
		September 30, 2014			September 30, 2013
	Interest rate cap	$	(7	)	$	(30	)
	Warrants issued with 8.00% Notes Issued in 2009	—			(6,323		)

	Compound embedded derivative with 8.00% Notes Issued in 2009	—			(29,986		)

	Contingent put feature embedded in the 5.0% Convertible Senior Notes	—			848

	Compound embedded derivative with 8.00% Notes Issued in 2013	43,050			(25,590		)

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	123,946			(36,453		)

	Total derivative gain (loss)	$	166,989		$	(97,534	)




		Nine Months Ended
		September 30, 2014			September 30, 2013
	Interest rate cap	$	(113	)	$	86

	Warrants issued with 8.00% Notes Issued in 2009	(67,523		)	(28,949		)
	Compound embedded derivative with 8.00% Notes Issued in 2009	(16,406		)	(37,233		)
	Contingent put feature embedded in the 5.0% Convertible Senior Notes	—			2,133

	Compound embedded derivative with 8.00% Notes Issued in 2013	(98,376		)	(26,495		)
	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(236,245		)	(36,453		)
	Total derivative loss	$	(418,663	)	$	(126,911	)

	Intangible and Other Assets

Interest Rate Cap

In June 2009, in connection with entering into the Facility Agreement, which provides for interest at a variable rate, the Company entered into five ten-year interest rate cap agreements. The interest rate cap agreements reflect a variable notional amount ranging from $586.3 million to $14.8 million at interest rates that provide coverage to the Company for exposure resulting from escalating interest rates over the term of the Facility Agreement. The interest rate cap provides limits on the six-month Libor rate (“Base Rate”) used to calculate the coupon interest on outstanding amounts on the Facility Agreement and is capped at 5.50% should the Base Rate not exceed 6.5%. Should the Base Rate exceed 6.5%, the Company’s Base Rate will be 1% less than the then six-month Libor rate. The Company paid an approximately $12.4 million upfront fee for the interest rate cap agreements. The interest rate cap did not qualify for hedge accounting treatment, and changes in the fair value of the agreements are included in the condensed consolidated statements of operations.

Derivative Liabilities

The Company has identified various embedded derivatives resulting from certain features in the Company’s debt instruments. These embedded derivatives required bifurcation from the debt host instrument. All embedded derivatives that required bifurcation are recorded as a derivative liability on the Company’s condensed consolidated balance sheet with a corresponding debt discount netted against the principal amount of the related debt instrument. The Company accretes the debt discount associated with each derivative liability to interest expense over the term of the related debt instrument using an effective interest rate method. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period with any changes in value reported in its condensed consolidated statements of operations. See below for further discussion for each liability and the features embedded in the debt instrument which required the Company to account for the instrument as a derivative.



Warrants Issued with 8.00% Notes Issued in 2009

Due to the reset features in the 8.00% Warrants issued with the 8.00% Notes Issued in 2009, the Company recorded the 8.00% Warrants as an embedded derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which was netted against the principal amount of the 8.00% Notes Issued in 2009. The Company determined the fair value of the warrant derivative using a Monte Carlo simulation model. The exercise period for the 8.00% Warrants expired in June 2014; accordingly, the derivative liability for the 8.00% Warrants is no longer outstanding.

Compound Embedded Derivative with 8.00% Notes Issued in 2009

As a result of the conversion rights and features and the contingent put feature embedded within the 8.00% Notes Issued in 2009, the Company recorded a compound embedded derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which was netted against the principal amount of the 8.00% Notes Issued in 2009. The Company determined the fair value of the compound embedded derivative using a Monte Carlo simulation model. On April 15, 2014, the remaining principal amount of 8.00% Notes Issued in 2009 was converted into common stock; accordingly, the derivative liability embedded in the 8.00% Notes Issued in 2009 is no longer outstanding.

Contingent Put Feature Embedded in the 5.0% Convertible Senior Notes

As a result of the contingent put feature within the 5.0% Convertible Senior Notes (“5.0% Notes”), the Company recorded a derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which was netted against the principal amount of the 5.0% Notes. The Company determined the fair value of the contingent put feature derivative using a Monte Carlo simulation model. On November 7, 2013, the remaining principal amount of the 5.0% Notes was converted into common stock; accordingly, the derivative liability embedded in the 5.0% Notes is no longer outstanding.

Compound Embedded Derivative with 8.00% Notes Issued in 2013

As a result of the conversion option and the contingent put feature within the 8.00% Notes Issued in 2013, the Company recorded a compound embedded derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the 8.00% Notes Issued in 2013. The Company determined the fair value of the compound embedded derivative liability using a blend of a Monte Carlo simulation model and market prices.

Compound Embedded Derivative with the Amended and Restated Thermo Loan Agreement

As a result of the conversion option and the contingent put feature within the Loan Agreement with Thermo entered into in July 2013, the Company recorded a compound embedded derivative liability on its condensed consolidated balance sheet with a corresponding debt discount which is netted against the face value of the Amended and Restated Loan Agreement. The Company determined the fair value of the compound embedded derivative liability using a blend of a Monte Carlo simulation model and market prices.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	FAIR VALUE MEASUREMENTS

	The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:

	Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

	Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.

	Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

	Recurring Fair Value Measurements

	The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013 (in thousands):



		Fair Value Measurements at September 30, 2014:
		(Level 1)				(Level 2)				(Level 3)				Total
														Balance
	Assets:

	Interest rate cap	$	—			$	72			$	—			$	72

	Total assets measured at fair value	$	—			$	72			$	—			$	72

	Liabilities:

	Derivative Liabilities:

	Compound embedded derivative with 8.00% Notes Issued in 2013	$	—			$	—			(109,896		)		$	(109,896	)

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—				—				(465,907		)		(465,907		)

	Total Derivative Liabilities	—				—				(575,803		)		(575,803		)

	Current Liabilities:

	Liability for contingent consideration	—				—				(1,149		)		(1,149		)

	Total liabilities measured at fair value	$	—			$	—			$	(576,952	)		$	(576,952	)




		Fair Value Measurements at December 31, 2013:
		(Level 1)				(Level 2)				(Level 3)				Total
														Balance
	Assets:

	Interest rate cap	$	—			$	185			$	—			$	185

	Total assets measured at fair value	$	—			$	185			$	—			$	185

	Liabilities:

	Derivative Liabilities:

	Warrants issued with 8.00% Notes Issued in 2009	$	—			$	—			$	(57,048	)		$	(57,048	)

	Compound embedded derivative with 8.00% Notes Issued in 2009	—				—				(66,022		)		(66,022		)

	Compound embedded derivative with 8.00% Notes Issued in 2013	—				—				(109,794		)		(109,794		)

Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—				—				(229,662		)		(229,662		)

Total Derivative Liabilities	—				—				(462,526		)		(462,526		)

Current Liabilities:

Liability for contingent consideration	—				—				(1,923		)		(1,923		)

Total liabilities measured at fair value	$	—			$	—			$	(464,449	)		$	(464,449	)


Assets

Interest Rate Cap

The fair value of the interest rate cap is determined using observable pricing inputs including benchmark yields, reported trades, and broker/dealer quotes at the reporting date. See Note 4 for further discussion.

Liabilities

The Company has various derivative liabilities in Level 3. The Company marks-to-market these liabilities at each reporting date with the changes in fair value recognized in the Company’s condensed consolidated statements of operations. See Note 4 for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of September 30, 2014 and December 31, 2013 are shown in the tables below:



	Level 3 Inputs at September 30, 2014:
	Stock Price		Risk-Free			Note				Warrant		Market Price of Common Stock
	Volatility		Interest			Conversion				Exercise
			Rate			Price				Price
Compound embedded derivative with 8.00% Notes Issued in 2013	65% - 95%		1.3	%		$	0.73			N/A		$	3.66

Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	50% - 90%		2.4	%		$	0.73			N/A		$	3.66




	Level 3 Inputs at December 31, 2013:
	Stock Price			Risk-Free			Note				Warrant				Market Price of Common Stock
	Volatility			Interest			Conversion				Exercise
				Rate			Price				Price
Compound embedded derivative with 8.00% Notes Issued in 2009	65% - 100%			1.5	%		$	1.14			N/A				$	1.75

Warrants issued with 8.00% Notes Issued in 2009	100	%		0.1	%		N/A				$	0.32			$	1.75

Compound embedded derivative with 8.00% Notes Issued in 2013	65% - 100%			1.5	%		$	0.73			N/A				$	1.75

Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	65% - 100%			3	%		$	0.73			N/A				$	1.75


Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases above the current conversion price for each of the related derivative instruments, the value to the holder of the instrument generally increases, thereby increasing the liability on the Company’s condensed consolidated balance sheet. As previously discussed, the Company uses a blend of a Monte Carlo simulation model and market prices to determine the fair value of the derivative valuations. These valuations are sensitive to the weighting applied to each of the simulated values. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the expected volatility of the Company's stock price. Decreases in expected volatility would generally result in a lower fair value measurement.

Probability of a change of control is another significant unobservable input used in the fair value measurement of the Company’s derivative instruments. Subject to certain restrictions in each indenture, the Company’s debt instruments contain certain provisions whereby holders may require the Company to purchase all or any portion of the convertible debt instrument upon a change of control. A change of control will occur upon certain changes in the ownership of the Company or certain events relating to the trading of the Company’s common stock. The simulated fair value of the derivative liabilities above is sensitive to changes in the assumed probabilities of a change of control. Decreases in the assumed probability of a change of control would generally result in a lower fair value measurement.

In addition to the Level 3 inputs described above, the indentures governing the related debt instrument for each of the derivative liabilities included in the Company’s Level 3 fair value measurements have specific features that impact the valuation of each liability at reporting periods. These features are further described below for each of the Company’s derivative liabilities.

Compound Embedded Derivative with 8.00% Notes Issued in 2009

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the 8.00% Notes Issued in 2009 included payment in kind interest payments, make whole premiums and automatic conversions. Pursuant to the terms of the 8.00% Notes Issued in 2009, the base conversion rate could not reset to lower than $1.00; therefore if the Company made future equity issuances at prices below the then current conversion price, this conversion price would have been adjusted downward to as low as $1.00. As discussed in Note 3, pursuant to the terms of the indenture governing the 8.00% Notes Issued in 2009, if at any time the closing price of the common stock had exceeded 200% of the conversion price of the 8.00% Notes Issued in 2009 then in effect for 30 consecutive trading days, all of the outstanding 8.00% Notes Issued in 2009 automatically would have been converted into common stock. This condition for the automatic conversion was met on April 15, 2014, and all outstanding 8.00% Notes Issued in 2009 converted into shares of the Company’s common stock; accordingly, this derivative liability is no longer outstanding.

Warrants Issued with 8.00% Notes Issued in 2009

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the 8.00% Warrants issued with the 8.00% Notes Issued in 2009 included certain reset features. Pursuant to the terms of the 8.00% Warrants, there was no floor within the reset feature for the exercise price of the 8.00% Warrants; therefore if the Company had made future equity issuances at prices below the current exercise price, this exercise price would have been adjusted downward. If the stock price on the issuance date had been less than the then current exercise price of the outstanding 8.00% Warrants, additional warrants would have been issued, which would have increased the fair value of the warrant liability. The exercise period for the 8.00% Warrants expired in June 2014; accordingly, this derivative liability is no longer outstanding.

Compound Embedded Derivative with 8.00% Notes Issued in 2013

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the Company’s 8.00% Notes Issued in 2013 includes payment in kind interest payments, make whole premiums, a 40-day stock issuance settlement period upon conversion and automatic conversions. Pursuant to the terms of the 8.00% Notes Issued in 2013 Indenture, there are also special distributions and certain put and call features within the notes which impact the valuation model. The trading activity in the market provides the Company with additional valuation support. In 2014, the Company implemented a weight factor to the fair value of the embedded derivative to align the fair value produced from the valuation model to the fair value of the notes traded in the market.

As previously described, fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. Given the stock price decline subsequent to September 30, 2014 and through the date of this report, there may be a material decrease in the compound embedded derivative within the Company's 8.00% Notes Issued in 2013 on the condensed consolidated balance sheet, and a material derivative gain on the condensed consolidated statement of operations, if the stock price does not recover prior to the next reporting date of December 31, 2014.

Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the Amended and Restated Loan Agreement with Thermo includes payment in kind interest payments, make whole premiums, a 40-day stock issuance settlement period upon conversion and automatic conversions. The compound embedded derivative in the Amended and Restated Loan Agreement with Thermo contains similar features to the 8.00% Notes Issued in 2013. As stated in the previous section, in 2014, the Company implemented a weight factor to the fair value of the embedded derivative in the 8.00% Notes Issued in 2013 to align the fair value produced from the valuation model to the fair value of the notes traded in the market. Due to the similarities in the debt instruments, a similar weight factor was applied to the embedded derivative in the Amended and Restated Loan Agreement with Thermo.

As previously described, fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. Given the decline in the Company's stock price subsequent to September 30, 2014, which has continued through the date of this report, there may be a material decrease in the compound embedded derivative within the Amended and Restated Loan Agreement with Thermo on the condensed consolidated balance sheet, and a material derivative gain on the condensed consolidated statement of operations, for the fourth quarter of 2014, to the extent that the stock price does not recover prior to December 31, 2014.

Other Liabilities

Liability for Contingent Consideration

In connection with the acquisition of Axonn LLC (“Axonn”) in December 2009, the Company is obligated to pay up to an additional $10.8 million in contingent consideration for earnouts based on sales of existing and new products over a five-year earnout period beginning January 1, 2010. The Company will make earnout payments in stock not to exceed 26,684,807 shares of common stock (10% of the Company’s pre-transaction outstanding shares of common stock), but at its option may make payments in cash after 13.0 million shares have been issued. The Company’s initial estimate of the total earnout expected to be paid was $10.8 million. Since the earnout period started, the Company has made revisions to this estimate, which was $9.8 million at September 30, 2014. Through September 30, 2014, the Company had made $8.7 million in earnout payments by issuing 18.7 million shares of voting common stock. The liability of $1.1 million recorded at September 30, 2014 represents the remaining projected earnout payments to be made under the agreement.

The fair value of the accrued contingent consideration was determined using a probability-weighted discounted cash flow approach at the acquisition date and reporting date. The approach is based on significant inputs that are not observable in the market, which are referred to as Level 3 inputs. The fair value is based on the Company's reaching specific performance metrics through the remaining earnout period. The change in fair value of the contingent consideration is recorded through accretion expense in the Company’s condensed consolidated statements of operations.

The significant unobservable inputs used in the fair value measurement of the Company’s liability for contingent consideration are projected future sales of existing and new products as well as earnout payments made each quarter determined by actual product sales. Decreases in forecasted sales would result in a lower fair value measurement.

The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2014 as follows (in thousands):



Balance at June 30, 2014	$	(775,361	)
Earnout payments made related to liability for contingent consideration	585

Change in fair value of contingent consideration	(189		)
Derivative adjustment related to conversions and exercises	31,017

Unrealized gain, included in derivative gain (loss)	166,996

Balance at September 30, 2014	$	(576,952	)



Balance at December 31, 2013	$	(464,449	)
Earnout payments made related to liability for contingent consideration	1,583

Change in fair value of contingent consideration	(809		)
Derivative adjustment related to conversions and exercises	305,274

Unrealized loss, included in derivative gain (loss)	(418,551		)
Balance at September 30, 2014	$	(576,952	)

Accrued_Expenses_and_NonCurren

Accrued Expenses and Non-Current Liabilities	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
Accrued Expenses and Non-Current Liabilities	'
	ACCRUED EXPENSES AND NON-CURRENT LIABILITIES

	Accrued expenses consist of the following (in thousands):



		September 30,		December 31,
		2014		2013
	Accrued interest	$	5,750	$	1,200

	Accrued compensation and benefits	2,552		3,927

	Accrued property and other taxes	5,366		5,744

	Accrued customer liabilities and deposits	2,822		2,663

	Accrued professional and other service provider fees	1,826		705

	Accrued liability for contingent consideration	1,149		1,922

	Accrued commissions	974		1,316

	Accrued telecommunications expenses	918		649

	Accrued second-generation constellation costs	1,887		—

	Other accrued expenses	2,622		4,574

	Total accrued expenses	$	25,866	$	22,700


	Other accrued expenses include primarily outsourced logistics services, storage, accruals for inventory in transit, warranty reserve, maintenance and payments to IGOs.

	Noncurrent liabilities consist of the following (in thousands):



		September 30,		December 31,
		2014		2013
	Long-term accrued interest	$	259	$	451

	Asset retirement obligation	1,158		1,083

	Deferred rent and capital lease obligations	433		456

	Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,594		1,575

	Uncertain income tax positions	6,704		5,918

	Foreign tax contingencies	3,839		4,213

	Total noncurrent liabilities	$	13,987	$	13,696

Commitments

Commitments	9 Months Ended
Commitments	Sep. 30, 2014
COMMITMENTS [Abstract]	'
Commitments	'
	COMMITMENTS

	Contractual Obligations

	As of September 30, 2014, the Company had purchase commitments with Thales Alenia Space France (“Thales”), Arianespace, Ericsson Inc. (“Ericsson”) and Hughes Network Systems, LLC (“Hughes”) related to the procurement and deployment of the second-generation network.

	Second-Generation Satellites

	As of September 30, 2014, the Company had a contract with Thales for the construction of the Company’s second-generation low-earth orbit satellites and related services. The Company has successfully launched all of these second-generation satellites, excluding one on-ground spare. The Company has also incurred additional costs for certain related services, of which a portion are still owed to Thales. Discussions between the Company and Thales are ongoing regarding the remaining amounts owed by both parties under the contract.

	As of September 30, 2014, the Company had a contract with Arianespace for the launch of the Company’s second-generation satellites and certain pre and post-launch services under which Arianespace agreed to make four launches of satellites. The Company has successfully completed all of these launches. The Company has also incurred additional costs which are owed to Arianespace for launch delays.

	Next-Generation Gateways and Other Ground Facilities

	As of September 30, 2014, the Company had a contract with Hughes under which Hughes will design, supply and implement the Radio Access Network (RAN) ground network equipment and software upgrades for installation at a number of the Company’s satellite gateway ground stations and satellite interface chips to be used in various next-generation Globalstar devices.

	In May 2014, the Company entered into an agreement with Hughes to incorporate changes to the scope of work for the RAN and UTS being supplied to the Company. The additional work increased the total contract value by $3.8 million. In May 2014, the Company and Hughes also entered into a letter agreement whereby Hughes was granted the option to accept the pre-payment of certain payment milestones in the form of Globalstar stock at a 7% discount from the market value in lieu of cash. These payment milestones totaled $9.9 million. The stock was issued to Hughes on July 1, 2014. In valuing the shares, a loss of approximately $0.7 million was recorded in the Company's condensed consolidated statement of operations during the second quarter of 2014.

	In October 2014, the Company and Hughes formally amended the contract to include the revised scope of work agreed to in the May letter agreement. The amendment also adjusted the schedule of the program and the remaining payment milestones and program milestones to incorporate the agreed upon changes. The additional $3.8 million in work agreed to in May is now reflected in the contract through this amendment.


	As of September 30, 2014, the Company had an agreement with Ericsson, which will work with the Company to develop, implement and maintain a ground interface, or core network system, that will be installed at a number of the Company’s satellite gateway ground stations. In July 2014, the Company and Ericsson entered into an amended and restated agreement for the Company’s core network system specifying the remaining contract value of $25.4 million for the work and a new milestone schedule to reflect the new program timeline.

	Since 2004, the Company has issued separate purchase orders for additional phone equipment and accessories under the terms of an executed commercial agreement with Qualcomm. This contract was canceled in March 2013 the parties thereafter sought to resolve the issues related to the contract termination. The Company and Qualcomm signed an agreement in July 2014 specifying terms for the sale of the remaining inventory to the Company. The Company previously recorded total advances to Qualcomm for inventory of $9.2 million on its condensed consolidated balance sheet. The Company agreed to pay to Qualcomm $0.1 million to take ownership of the finished goods and raw materials held by Qualcomm, as well as certain limited support services to be provided to the Company. This final payment was made in July 2014 and eliminated Globalstar's obligations to purchase additional equipment from Qualcomm. As a result of certain terms in the July 2014 agreement, the Company recorded a reduction in the value of inventory of $7.3 million related to raw materials that are not likely to be used in the future production of inventory. With the final payment of $0.1 million made in July, the Company assumed title to the inventory; therefore, the remaining balance of approximately $2.0 million, representing primarily finished goods, is included in inventory on the Company's condensed consolidated balance sheet as of September 30, 2014.

Contingencies

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2014
CONTINGENCIES [Abstract]	'
Contingencies	'
	CONTINGENCIES

	Arbitration

	On June 3, 2011, Globalstar filed a demand for arbitration against Thales before the American Arbitration Association to enforce certain rights to order additional satellites under the Amended and Restated Contract for the construction of the Globalstar Satellite for the Second Generation Constellation dated and executed in June 2009 (“2009 Contract”). Globalstar did not include within its demand any claims that it had against Thales for work previously performed under the contract to design, manufacture and timely deliver the first 25 second-generation satellites. On May 10, 2012, the arbitration tribunal issued its award in which it determined that Globalstar materially breached the contract by failing to pay to Thales termination charges in the amount of €51,330,875.00 by October 9, 2011, and that absent further agreement between the parties, Thales has no further obligation to manufacture or deliver satellites under Phase 3 of the 2009 Contract. The award also required Globalstar to pay Thales approximately €53 million in termination charges and interest by June 9, 2012. On May 23, 2012, Thales commenced an action in the United States District Court for the Southern District of New York by filing a petition to confirm the arbitration award (the “New York Proceeding”). Thales and the Company entered into a Tolling Agreement as of June 13, 2013 under which Thales dismissed the New York Proceeding without prejudice. Thales may refile the petition at a later date and pursue the confirmation of the arbitration award, which Globalstar will oppose. Should Thales be successful in confirming the arbitration award, this would have a material adverse effect on the Company’s financial condition and liquidity.

	On June 24, 2012, the Company and Thales agreed to settle their prior commercial disputes, including those disputes that were the subject of the arbitration award. In order to effectuate this settlement, the Company and Thales entered into a Release Agreement, a Settlement Agreement and a Submission Agreement. Under the terms of the Release Agreement, Thales agreed unconditionally and irrevocably to release and forever discharge the Company from any obligation to pay €35,623,770 of the termination charges awarded in the arbitration together with all interest on the award amount effective upon the earlier of December 31, 2012 and the effective date of the financing for the purchase of any additional second-generation satellites. Under the terms of the Release Agreement, Globalstar agreed unconditionally and irrevocably to release and forever discharge Thales from any and all claims related to Thales’ work under the 2009 satellite construction contract, including any obligation to pay liquidated damages, effective upon the earlier of December 31, 2012 and the effective date of the financing for the purchase of any additional second-generation satellites. In connection with the Release Agreement, the Company recorded a contract termination charge of approximately €17.5 million which is recorded in the Company’s condensed consolidated financial statements for the period ended September 30, 2014. The releases became effective on December 31, 2012.

	Under the terms of the Settlement Agreement, Globalstar agreed to pay €17,530,000 to Thales, representing one-third of the termination charges awarded to Thales in the arbitration, subject to certain conditions, on the later of the effective date of the new contract for the purchase of any additional second-generation satellites and the effective date of the financing for the purchase of these satellites. Because the effective date of the new contract for the purchase of additional second-generation satellites did not occur on or prior to February 28, 2013, any party may terminate the Settlement Agreement. If any party terminates the Settlement Agreement, all parties’ rights and obligations under the Settlement Agreement shall terminate. However, the Release Agreement provides that it will survive a termination of the Settlement Agreement. As of September 30, 2014, no party had terminated the Settlement Agreement.

	Litigation

	Due to the nature of the Company's business, the Company is involved, from time to time, in various litigation matters or subject to disputes or routine claims regarding its business activities. Legal costs related to these matters are expensed as incurred. In management's opinion, there is no pending litigation, dispute or claim, other than the arbitration award discussed above, that may have a material adverse effect on the Company's financial condition, results of operations or liquidity.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	RELATED PARTY TRANSACTIONS

	Payables to Thermo and other affiliates relate to normal purchase transactions and were $0.4 million and $0.2 million at September 30, 2014 and December 31, 2013, respectively.

	Transactions with Thermo

	Thermo incurs certain expenses on behalf of the Company. The table below summarizes the total expense for the periods indicated below (in thousands):



		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	General and administrative expenses	$	174	$	74	$	236	$	229

	Non-cash expenses	137		137		411		411

	Loss on equity issuance	—		2,404		—		16,373

	Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	—		66,088		—		$	66,088

	Total	$	311	$	68,703	$	647	$	83,101


	General and administrative expenses are related to expenses incurred by Thermo on the Company’s behalf which are charged to the Company. Non-cash expenses are related to services provided by two executive officers of Thermo (who are also directors of the Company) who receive no cash compensation from the Company; these expenses are treated as a contribution to capital. The Thermo expenses are based on actual amounts (with no mark-up) incurred or upon allocated employee time.

	Since June 2009, Thermo and its affiliates have also deposited $60.0 million into a contingent equity account to fulfill a condition precedent for borrowing under the Facility Agreement, purchased $20.0 million of the Company’s 5.0% Notes, purchased $11.4 million of the Company's 8.00% Notes Issued in 2009, provided a $2.3 million short-term loan to the Company (which was subsequently converted into nonvoting common stock), and loaned $37.5 million to the Company to fund the debt service reserve account.

	On May 20, 2013, the Company issued 8.00% Notes Issued in 2013 and other consideration in exchange for its outstanding 5.75% Notes. In connection with this exchange, the Company entered into the Consent Agreement, the Common Stock Purchase Agreement and the Common Stock Purchase and Option Agreement (see Note 3 for further discussion). As a result of these transactions, during 2013 the Company recognized a loss on the sale of shares of approximately $16.4 million (which is included in other income/expense on the condensed consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company's common stock (measured as the closing stock price on the date of each sale).

	In August 2013, the Company drew the remaining $1.1 million from the interest earned on the contingent equity account under the Facility Agreement and in October 2013 issued 2,133,656 shares of nonvoting common stock to Thermo. The value of the 20% discount on the shares issued to Thermo was recorded as a deferred financing cost on the Company's condensed consolidated balance sheet as of September 30, 2013.

	In July 2013, the Company and Thermo entered into an Amended and Restated Loan Agreement. As a result of this transaction, the Company was required to record this Loan Agreement initially at fair value as the amendment and restatement of the Loan Agreement was considered to be an extinguishment of debt. As of the amendment and restatement date the fair value of the Loan Agreement was $120.1 million. The Company recorded a loss on extinguishment of debt of $66.1 million in its condensed consolidated statement of operations for the third quarter of 2013. The Company computed this loss as the difference between the fair value of the debt, as amended and restated, and its carrying value just prior to amendment and restatement.

	The terms of the Amended and Restated Loan Agreement with Thermo, the Common Stock Purchase and the Common Stock Purchase and Option Agreement were approved by a special committee of the Company's board of directors consisting solely of the Company's unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of these agreements were fair and in the best interests of the Company and its shareholders.

	During the second quarter of 2014, Thermo exercised warrants that were scheduled to expire in June 2014. The warrants that were exercised in the second quarter of 2014 included warrants for 4.2 million shares issued as partial consideration for the Thermo Loan Agreement, resulting in the issuance of 4.2 million shares of Globalstar common stock; warrants for 4.4 million shares issued in connection with the annual availability fee for the Contingent Equity Agreement in 2009, resulting in the issuance of 4.4 million shares of Globalstar common stock; and 16.3 million 8.00% Warrants issued in 2009, resulting in the issuance of 14.7 million shares of Globalstar common stock. As of September 30, 2014, warrants to purchase approximately 37.1 million shares issued under the Contingent Equity Agreement and 8.0 million 5.0% Warrants remain outstanding, all of which are held by Thermo and are scheduled to expire between December 2014 and June 2017.

	Thermo is required to maintain minimum ownership levels in the Company's common stock as defined in the Facility Agreement. As needed, Thermo may convert shares of nonvoting common stock into shares of voting common stock to ensure compliance with these ownership levels. During August 2014, Thermo converted 75 million shares of nonvoting common stock to voting common stock for this purpose.

	See Note 3 for further discussion of the Company's debt and financing transactions with Thermo.

Income_Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES

	The Company follows authoritative guidance surrounding accounting for uncertainty in income taxes. The Company's policy is to recognize interest and applicable penalties, if any, related to uncertain tax positions in income tax expense. For the periods ending September 30, 2014 and December 31, 2013, the net deferred tax assets were fully reserved.

	In January 2012, the Company’s Canadian subsidiary was notified that its income tax returns for the years ended October 31, 2008 and 2009 had been selected for audit. The Canada Revenue Agency is in the process of reviewing the information provided by the Canadian subsidiary.

	In December 2013, the Company’s Singapore subsidiary was notified that its income tax returns for the years ended 2009 to 2012 had been selected for audit. The Inland Revenue Authority reviewed the submitted information and had minimal adjustments to the Singapore subsidiary's total net operating loss carried forward schedule.

	Except for the audits noted above, neither the Company nor any of its subsidiaries is currently under audit by the IRS, any state jurisdiction in the United States or any foreign jurisdiction. The Company's corporate U.S. tax returns for 2010 and subsequent years remain subject to examination by tax authorities. State income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

	The Company has not provided United States income taxes and foreign withholding taxes on approximately $12.2 million of undistributed earnings from certain foreign subsidiaries indefinitely invested outside the United States. Should the Company decide to repatriate these foreign earnings, the Company would have to adjust the income tax provision in the period in which management believes the Company would repatriate the earnings.

	On September 13, 2013, Treasury and the Internal Revenue Service issued final regulations regarding the deduction and capitalization of expenditures related to tangible property. The final regulations under Internal Revenue Code Sections 162, 167 and 263(a) apply to amounts paid to acquire, produce, or improve tangible property as well as dispositions of such property and are generally effective for tax years beginning on or after January 1, 2014. The Company has evaluated these regulations and determined they will not have a material impact on its consolidated results of operations, cash flows or financial position.

	Through a prior foreign acquisition, the Company acquired a tax liability for which the Company has been indemnified by the previous owners. As of September 30, 2014 and December 31, 2013, the Company had recorded a tax liability of $2.1 million and $2.2 million, respectively, to the foreign tax authorities with an offsetting tax receivable from the previous owners.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 30, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'
Accumulated Other Comprehensive Income (Loss)	'
	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

	Accumulated other comprehensive income (loss) includes all changes in equity during a period from non-owner sources. The change in accumulated other comprehensive loss for all periods presented resulted from foreign currency translation adjustments.

	The components of accumulated other comprehensive income (loss) were as follows (in thousands):



		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Accumulated other comprehensive income (loss), June 30, 2014 and 2013 and December 31, 2013 and 2012, respectively	$	493		$	(2,408	)	$	871		$	(1,758	)

	Other comprehensive income (loss) :

	Foreign currency translation adjustments	(493		)	553			(871		)	(97		)

	Accumulated other comprehensive income (loss), September 30, 2014 and 2013, respectively	$	—		$	(1,855	)	$	—		$	(1,855	)


	No amounts were reclassified out of accumulated other comprehensive income (loss) for the periods shown above.

Stock_Compensation

Stock Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock Compensation	'
	STOCK COMPENSATION

	The Company’s 2006 Equity Incentive Plan (“Equity Plan”) provides long-term incentives to the Company’s key employees, including officers, directors, consultants and advisers (“Eligible Participants”) and to align stockholder and employee interests. Under the Equity Plan, the Company may grant incentive stock options, restricted stock awards, restricted stock units, and other stock based awards or any combination thereof to Eligible Participants. The Compensation Committee of the Company’s board of directors establishes the terms and conditions of any awards granted under the plans.

	For the three months ended September 30, 2014 and 2013, the Company recorded compensation expense related to these plans of $1.1 million and $1.0 million, respectively. For the nine months ended September 30, 2014 and 2013, the Company recorded compensation expense related to these plans of $2.1 million and $1.7 million, respectively. These expenses are reflected in marketing, general and administrative expenses. In the third quarter 2013, the Company's stock price traded for more than ten consecutive trading days at a price above $0.80, triggering immediate vesting of nonstatutory stock options and restricted stock granted in October 2011. This vesting resulted in recognition of compensation expense of $0.8 million, which is included in the amount of compensation expense above for the three and nine months ended September 30, 2013.

	Grants to Eligible Participants of incentive stock options, restricted stock awards, and restricted stock units during the period are indicated in the table below (in thousands):



		Three Months Ended September 30,		Nine Months Ended September 30,
		2014	2013	2014	2013
	Grants of restricted stock awards and restricted stock units	201	14	607	852

	Grants of options to purchase common stock	134	1,224	595	1,829

	Total	335	1,238	1,202	2,681


	Employee Stock Purchase Plan

	The Company’s Employee Stock Purchase Plan (the “Plan”) provides eligible employees of the Company and its subsidiaries with an opportunity to acquire shares of its common stock at a discount. The Plan permits eligible employees to purchase shares of common stock during two semi-annual offering periods beginning on June 15 and December 15, unless adjusted by the Board or one of its designated committees (the “Offering Periods”). Eligible employees may purchase shares in an amount of up to 15% of their total compensation per pay period, but may purchase no more than the lesser of $25,000 fair market value of common stock or 500,000 shares of common stock in any calendar year, as measured as of the first day of each applicable Offering Period. The price an employee pays is 85% of the fair market value of the common stock. Fair market value is equal to the lesser of the closing price of a share of common stock on either the first or last day of the Offering Period.

	For each of the three and nine months ended September 30, 2014 and 2013, the Company recorded expense for the fair value of the grant of $0.1 million and $0.2 million, respectively, which is reflected in marketing, general and administrative expenses. Through September 30, 2014, the Company had issued 2,486,902 shares of common stock pursuant to this Plan.

Geographic_Information

Geographic Information	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Geographic Information	'
	GEOGRAPHIC INFORMATION

	The Company attributes equipment revenue to various countries based on the location equipment is sold. Service revenue is attributed to the various countries based on where the service is processed. Long-lived assets consist primarily of property and equipment and are attributed to various countries based on the physical location of the asset at a given fiscal year-end, except for the satellites which are included in the long-lived assets of the United States. The Company’s information by geographic area is as follows (in thousands):



		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Revenues:

	Service:

	United States	$	12,267	$	11,660	$	35,000	$	33,666

	Canada	4,077		3,446		10,946		9,123

	Europe	1,655		1,185		4,407		2,736

	Central and South America	440		625		1,886		1,918

	Others	72		140		408		411

	Total service revenue	$	18,511	$	17,056	$	52,647	$	47,854

	Subscriber equipment:

	United States	2,510		3,688		8,340		8,756

	Canada	1,418		1,201		4,187		2,964

	Europe	540		327		1,628		1,228

	Central and South America	437		177		930		712

	Others	25		100		239		203

	Total subscriber equipment revenue	$	4,930	$	5,493	$	15,324	$	13,863

	Total revenue	$	23,441	$	22,549	$	67,971	$	61,717




		September 30,		December 31,
		2014		2013
	Long-lived assets:

	United States	$	1,114,934	$	1,164,358

	Canada	318		247

	Europe	470		408

	Central and South America	3,510		3,595

	Others	924		1,177

	Total long-lived assets	$	1,120,156	$	1,169,785

Earning_Loss_Per_Share

Earning (Loss) Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earning (Loss) Per Share	'
	EARNINGS (LOSS) PER SHARE

	The Company is required to present basic and diluted earnings per share. Basic earnings per share are computed based on the weighted average number of common shares outstanding during the period. Common stock equivalents are included in the calculation of diluted earnings per share only when the effect of their inclusion would be dilutive.

	The following table reconciles basic weighted average common shares to diluted weighted average common shares outstanding for the three months ended September 30, 2014 (in thousands):



		Three Months Ended September 30, 2014
	Weighted average common shares outstanding:
	Basic shares outstanding	987,668

	Incremental shares from assumed exercises of:
	Stock options, restricted stock, restricted stock units and ESPP	7,340

	8% Convertible Senior Notes Issued in 2013	39,625

	Thermo Loan Agreement	109,469

	Warrants	45,088

	Diluted shares outstanding	1,189,190



	For the three months ended September 30, 2014, net income was adjusted for interest expense (net of capitalized amounts) related to the 8% Convertible Senior Notes Issued in 2013 and the Thermo Loan Agreement for the computation of diluted earnings per share as these notes were assumed to be converted at the start of the period. There were no anti-dilutive stock options, restricted stock or restricted stock units excluded from diluted shares outstanding for the third quarter of 2014.

	For the three months ended September 30, 2013 and nine months ended September 30, 2014 and 2013, diluted net loss per share of common stock was the same as basic net loss per share of common stock because the effects of potentially dilutive securities are anti-dilutive.

Supplemental_Condensed_Consoli

Supplemental Condensed Consolidating Financial Information	9 Months Ended
	Sep. 30, 2014
SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]	'
Supplemental Condensed Consolidating Financial Information	'
	SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

	In connection with the Company’s issuance of the 8.00% Notes issued in 2013, certain of the Company’s 100% owned domestic subsidiaries (the “Guarantor Subsidiaries”), fully, unconditionally, jointly, and severally guaranteed the payment obligations under the 8.00% Notes Issued in 2013. The following supplemental financial information sets forth, on a consolidating basis, the balance sheets, statements of operations and statements of cash flows for Globalstar, Inc. (“Parent Company”), for the Guarantor Subsidiaries and for the Parent Company’s other subsidiaries (the “Non-Guarantor Subsidiaries”).

	The supplemental condensed consolidating financial information has been prepared pursuant to the rules and regulations for condensed financial information and does not include disclosures included in annual financial statements. The principal eliminating entries eliminate investments in subsidiaries, intercompany balances and intercompany revenues and expenses.

	Globalstar, Inc.
	Supplemental Condensed Consolidating Statement of Operations
	Three Months Ended September 30, 2014
	(Unaudited)



		Parent				Guarantor				Non-				Eliminations				Consolidated
		Company				Subsidiaries				Guarantor
										Subsidiaries
		(In thousands)
	Revenues:

	Service revenues	$	19,258			$	1,494			$	6,389			$	(8,630	)		$	18,511

	Subscriber equipment sales	71				3,471				5,118				(3,730		)		4,930

	Total revenue	19,329				4,965				11,507				(12,360		)		23,441

	Operating expenses:

	Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	2,903				2,653				2,563				(251		)		7,868

	Cost of subscriber equipment sales	31				2,962				4,823				(3,980		)		3,836

	Cost of subscriber equipment sales - reduction in the value of inventory	—				—				—				—				—

	Marketing, general and administrative	1,906				3,850				4,408				(1,381		)		8,783

	Depreciation, amortization, and accretion	19,180				1,879				6,974				(6,986		)		21,047

	Total operating expenses	24,020				11,344				18,768				(12,598		)		41,534

	Loss from operations	(4,691		)		(6,379		)		(7,261		)		238				(18,093		)

	Other income (expense):

	Loss on extinguishment of debt	(12,936		)		—				—				—				(12,936		)

	Interest income and expense, net of amounts capitalized	(9,001		)		(10		)		(57		)		1				(9,067		)

	Derivative gain	166,989				—				—				—				166,989

	Equity in subsidiary earnings	(12,653		)		(884		)		—				13,537				—

	Other	1,782				409				364				31				2,586

	Total other income (expense)	134,181				(485		)		307				13,569				147,572

	Income (loss) before income taxes	129,490				(6,864		)		(6,954		)		13,807				129,479

	Income tax expense	100				7				(18		)		—				89

	Net income (loss)	$	129,390			$	(6,871	)		$	(6,936	)		$	13,807			$	129,390

	Comprehensive income (loss)	$	129,390			$	(6,871	)		$	(7,430	)		$	13,807			$	128,896


Globalstar, Inc.
Supplemental Condensed Consolidating Statement of Operations
Three Months Ended September 30, 2013
(Unaudited)


	Parent				Guarantor				Non-				Eliminations				Consolidated
	Company				Subsidiaries				Guarantor
									Subsidiaries
	(In thousands)
Revenues:

Service revenues	$	18,726			$	2,478			$	4,940			$	(9,088	)		$	17,056

Subscriber equipment sales	127				4,254				1,070				42				5,493

Total revenue	18,853				6,732				6,010				(9,046		)		22,549

Operating expenses:

Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	3,125				3,126				1,941				(11		)		8,181

Cost of subscriber equipment sales	90				3,334				1,819				(1,095		)		4,148

Marketing, general and administrative	2,008				4,666				3,774				(1,369		)		9,079

Depreciation, amortization, and accretion	19,645				4,914				6,485				(7,329		)		23,715

Total operating expenses	24,868				16,040				14,019				(9,804		)		45,123

Loss from operations	(6,015		)		(9,308		)		(8,009		)		758				(22,574		)

Other income (expense):

Loss on extinguishment of debt	(63,569		)		—				—				—				(63,569		)

Loss on equity issuance	(2,733		)		—				—				—				(2,733		)

Interest income and expense, net of amounts capitalized	(16,636		)		(3		)		(262		)		—				(16,901		)

Derivative loss	(97,534		)		—				—				—				(97,534		)

Equity in subsidiary earnings	(17,090		)		(1,729		)		—				18,819				—

Other	(1,343		)		(171		)		(21		)		(5		)		(1,540		)
Total other income (expense)	(198,905		)		(1,903		)		(283		)		18,814				(182,277		)

Loss before income taxes	(204,920		)		(11,211		)		(8,292		)		19,572				(204,851		)

Income tax expense	49				6				63				—				118

Net (loss) income	$	(204,969	)		$	(11,217	)		$	(8,355	)		$	19,572			$	(204,969	)

Comprehensive (loss) income	$	(204,969	)		$	(11,217	)		$	(7,803	)		$	19,572			$	(204,417	)



Globalstar, Inc.
Supplemental Condensed Consolidating Statement of Operations
Nine Months Ended September 30, 2014
(Unaudited)



	Parent				Guarantor				Non-				Eliminations				Consolidated
	Company				Subsidiaries				Guarantor
									Subsidiaries
	(In thousands)
Revenues:

Service revenues	$	56,627			$	4,859			$	17,279			$	(26,118	)		$	52,647

Subscriber equipment sales	387				10,966				9,271				(5,300		)		15,324

Total revenue	57,014				15,825				26,550				(31,418		)		67,971

Operating expenses:

Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	7,958				7,101				7,289				(422		)		21,926

Cost of subscriber equipment sales	243				8,578				9,415				(6,996		)		11,240

Cost of subscriber equipment sales - reduction in the value of inventory	7,258				19				40				—				7,317

Marketing, general and administrative	5,501				11,994				10,910				(3,606		)		24,799

Depreciation, amortization, and accretion	57,636				9,589				20,113				(20,945		)		66,393

Total operating expenses	78,596				37,281				47,767				(31,969		)		131,675

Loss from operations	(21,582		)		(21,456		)		(21,217		)		551				(63,704		)

Other income (expense):

Loss on extinguishment of debt	(39,615		)		—				—				—				(39,615		)

Interest income and expense, net of amounts capitalized	(33,598		)		(30		)		(226		)		1				(33,853		)

Derivative loss	(418,663		)		—				—				—				(418,663		)

Equity in subsidiary earnings	(42,471		)		(5,100		)		—				47,571				—

Other	1,250				400				643				(86		)		2,207

Total other income (expense)	(533,097		)		(4,730		)		417				47,486				(489,924		)

Loss before income taxes	(554,679		)		(26,186		)		(20,800		)		48,037				(553,628		)

Income tax expense	204				34				1,017				—				1,255

Net (loss) income	$	(554,883	)		$	(26,220	)		$	(21,817	)		$	48,037			$	(554,883	)

Comprehensive (loss) income	$	(554,883	)		$	(26,220	)		$	(22,688	)		$	48,037			$	(555,754	)



Globalstar, Inc.
Supplemental Condensed Consolidating Statement of Operations
Nine Months Ended September 30, 2013
(Unaudited)


	Parent				Guarantor				Non-				Eliminations				Consolidated
	Company				Subsidiaries				Guarantor
									Subsidiaries
	(In thousands)
Revenues:

Service revenues	$	50,351			$	8,544			$	13,320			$	(24,361	)		$	47,854

Subscriber equipment sales	287				10,018				13,264				(9,706		)		13,863

Total revenue	50,638				18,562				26,584				(34,067		)		61,717

Operating expenses:

Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	8,233				7,947				6,791				(58		)		22,913

Cost of subscriber equipment sales	90				8,048				14,323				(11,786		)		10,675

Marketing, general and administrative	4,555				11,710				9,895				(3,581		)		22,579

Depreciation, amortization, and accretion	52,538				15,936				17,167				(19,527		)		66,114

Total operating expenses	65,416				43,641				48,176				(34,952		)		122,281

Loss from operations	(14,778		)		(25,079		)		(21,592		)		885				(60,564		)

Other income (expense):

Loss on extinguishment of debt	(110,809		)		—				—				—				(110,809		)

Loss on equity issuance	(16,701		)		—				—				—				(16,701		)

Interest income and expense, net of amounts capitalized	(38,728		)		(39		)		(1,098		)		(4		)		(39,869		)
Derivative loss	(126,911		)		—				—				—				(126,911		)

Equity in subsidiary earnings	(47,313		)		(2,794		)		—				50,107				—

Other	(909		)		(170		)		(124		)		78				(1,125		)

Total other income (expense)	(341,371		)		(3,003		)		(1,222		)		50,181				(295,415		)

Loss before income taxes	(356,149		)		(28,082		)		(22,814		)		51,066				(355,979		)

Income tax expense	171				35				135				—				341

Net (loss) income	$	(356,320	)		$	(28,117	)		$	(22,949	)		$	51,066			$	(356,320	)

Comprehensive (loss) income	$	(356,320	)		$	(28,117	)		$	(23,046	)		$	51,066			$	(356,417	)


Globalstar, Inc.
Supplemental Condensed Consolidating Balance Sheet
As of September 30, 2014
(Unaudited)



	Parent				Guarantor				Non-Guarantor				Elimination				Consolidated
	Company				Subsidiaries				Subsidiaries
	(In thousands)
ASSETS

Current assets:

Cash and cash equivalents	$	22,921			$	912			$	3,388			$	—			$	27,221

Accounts receivable	4,582				6,151				5,227				257				16,217

Intercompany receivables	727,100				436,281				23,711				(1,187,092		)		—

Inventory	4,122				12,419				12,736				—				29,277

Advances for inventory	125				28				43				—				196

Prepaid expenses and other current assets	4,374				278				2,804				—				7,456

Total current assets	763,224				456,069				47,909				(1,186,835		)		80,367

Property and equipment, net	1,111,237				3,697				6,277				(1,055		)		1,120,156

Restricted cash	37,918				—				—				—				37,918

Intercompany notes receivable	13,006				—				4,885				(17,891		)		—

Investment in subsidiaries	(241,579		)		4,216				29,382				207,981				—

Deferred financing costs	66,816				—				—				—				66,816

Intangible and other assets, net	11,999				671				2,047				(14		)		14,703

Total assets	$	1,762,621			$	464,653			$	90,500			$	(997,814	)		$	1,319,960

LIABILITIES AND
STOCKHOLDERS’ EQUITY
Current liabilities:

Current portion of long-term debt	$	7,271			$	—			$	—			$	—			$	7,271

Accounts payable	8,112				2,045				2,038				—				12,195

Accrued contract termination charge	22,238				—				—				—				22,238

Accrued expenses	11,122				7,195				7,549				—				25,866

Intercompany payables	492,868				552,218				144,152				(1,189,238		)		—

Payables to affiliates	443				—				—				—				443

Deferred revenue	2,885				16,092				3,214				—				22,191

Total current liabilities	544,939				577,550				156,953				(1,189,238		)		90,204

Long-term debt, less current portion	623,770				—				—				—				623,770

Employee benefit obligations	3,147				—				(1		)		—				3,146

Intercompany notes payable	—				—				15,448				(15,448		)		—

Derivative liabilities	575,803				—				—				—				575,803

Deferred revenue	6,330				457				—				—				6,787

Debt restructuring fees	20,795				—				—				—				20,795

Other non-current liabilities	2,369				293				11,325				—				13,987

Total non-current liabilities	1,232,214				750				26,772				(15,448		)		1,244,288

Stockholders’ equity	(14,532		)		(113,647		)		(93,225		)		206,872				(14,532		)

Total liabilities and stockholders’ equity	$	1,762,621			$	464,653			$	90,500			$	(997,814	)		$	1,319,960


Globalstar, Inc.
Supplemental Condensed Consolidating Balance Sheet
As of December 31, 2013
(Audited)



	Parent				Guarantor				Non-Guarantor				Elimination				Consolidated
	Company				Subsidiaries				Subsidiaries
	(In thousands)
ASSETS

Current assets:

Cash and cash equivalents	$	12,935			$	676			$	3,797			$	—			$	17,408

Accounts receivable	5,925				5,022				4,602				174				15,723

Intercompany receivables	651,251				414,508				18,280				(1,084,039		)		—

Inventory	1,161				14,375				16,281				—				31,817

Advances for inventory	9,287				28				44				—				9,359

Prepaid expenses and other current assets	4,316				311				2,432				—				7,059

Total current assets	684,875				434,920				45,436				(1,083,865		)		81,366

Property and equipment, net	1,152,734				11,621				6,889				(1,459		)		1,169,785

Restricted cash	37,918				—				—				—				37,918

Intercompany notes receivable	13,629				—				4,285				(17,914		)		—

Investment in subsidiaries	(209,592		)		7,242				—				202,350				—

Deferred financing costs	76,436				—				—				—				76,436

Intangible and other assets, net	3,964				1,028				2,125				(14		)		7,103

Total assets	$	1,759,964			$	454,811			$	58,735			$	(900,902	)		$	1,372,608

LIABILITIES AND
STOCKHOLDERS’ EQUITY
Current liabilities:

Current portion of long-term debt	$	4,046			$	—			$	—			$	—			4,046

Accounts payable	9,906				2,041				2,680				—				14,627

Accrued contract termination charge	24,133				—				—				—				24,133

Accrued expenses	6,160				8,203				8,337				—				22,700

Intercompany payables	435,707				521,763				128,496				(1,085,966		)		—

Payables to affiliates	202				—				—				—				202

Derivative liabilities	57,048				—				—				—				57,048

Deferred revenue	1,843				13,094				2,347				—				17,284

Total current liabilities	539,045				545,101				141,860				(1,085,966		)		140,040

Long-term debt, less current portion	665,236				—				—				—				665,236

Employee benefit obligations	3,529				—				—				—				3,529

Intercompany notes payable	—				—				15,772				(15,772		)		—

Derivative liabilities	405,478				—				—				—				405,478

Deferred revenue	6,583				496				—				—				7,079

Debt restructuring fees	20,795				—				—				—				20,795

Other non-current liabilities	2,543				297				10,856				—				13,696

Total non-current liabilities	1,104,164				793				26,628				(15,772		)		1,115,813

Stockholders’ equity	116,755				(91,083		)		(109,753		)		200,836				116,755

Total liabilities and stockholders’ equity	$	1,759,964			$	454,811			$	58,735			$	(900,902	)		$	1,372,608


Globalstar, Inc.
Supplemental Condensed Consolidating Statement of Cash Flows
Nine Months Ended September 30, 2014
(Unaudited)



	Parent				Guarantor				Non-				Eliminations				Consolidated
	Company				Subsidiaries				Guarantor
									Subsidiaries
	(In thousands)
Net cash provided by (used in) operating activities	$	6,066			$	728			$	81			$	—			$	6,875

Cash flows from investing activities:

Second-generation satellites, ground and related launch costs	(3,862		)		—				—				—				(3,862		)

Property and equipment additions	(1,357		)		(492		)		(354		)		—				(2,203		)

Net cash used in investing activities	(5,219		)		(492		)		(354		)		—				(6,065		)

Cash flows provided by (used in) financing activities:

Proceeds from issuance of common stock and exercise of warrants	9,303				—				—				—				9,303

Payment of deferred financing costs	(164		)		—				—				—				(164		)

Net cash used in financing activities	9,139				—				—				—				9,139

Effect of exchange rate changes on cash and cash equivalents	—				—				(136		)		—				(136		)

Net increase (decrease) in cash and cash equivalents	9,986				236				(409		)		—				9,813

Cash and cash equivalents at beginning of period	12,935				676				3,797				—				17,408

Cash and cash equivalents at end of period	$	22,921			$	912			$	3,388			$	—			$	27,221


Globalstar, Inc.
Supplemental Condensed Consolidating Statement of Cash Flows
Nine Months Ended September 30, 2013
(Unaudited)



	Parent				Guarantor				Non-				Eliminations				Consolidated
	Company				Subsidiaries				Guarantor
									Subsidiaries
	(In thousands)
Net cash provided used in operating activities	$	426			$	814			$	1,094			$	—			$	2,334

Cash flows from investing activities:

Second-generation satellites, ground and related launch costs	(37,732		)		—				—				—				(37,732		)

Property and equipment additions	—				(706		)		(519		)		—				(1,225		)

Investment in businesses	(496		)		—				—				—				(496		)

Restricted cash	8,838				—				—				—				8,838

Net cash from investing activities	(29,390		)		(706		)		(519		)		—				(30,615		)

Cash flows from financing activities:

Borrowings from Facility Agreement	672																672

Borrowings from contingent equity account	1,071																1,071

Proceeds from issuance of common stock and stock options	8,979				—				—				—				8,979

Payments to reduce principal amount of exchanged 5.75% Notes	(13,544		)		—				—				—				(13,544		)

Payments to reduce principal amount of 5.75% Notes not exchanged	(6,250		)		—				—				—				(6,250		)

Payments to lenders and other fees associated with exchange	(2,482		)		—				—				—				(2,482		)

Proceeds from equity issuance to related party	51,500				—				—				—				51,500

Payment of deferred financing costs	(16,904		)		—				—				—				(16,904		)

Net cash used in financing activities	23,042				—				—				—				23,042

Effect of exchange rate changes on cash and cash equivalents	—				—				90				—				90

Net increase (decrease) in cash and cash equivalents	(5,922		)		108				665				—				(5,149		)

Cash and cash equivalents at beginning of period	10,220				251				1,321				—				11,792

Cash and cash equivalents at end of period	$	4,298			$	359			$	1,986			$	—			$	6,643

Basis_of_Presentation_Basis_of

Basis of Presentation Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation Basis of Presentation (Policies)	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Recent Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements

	In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. This standard requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is currently evaluating the impact this standard will have on its condensed consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing reporting.

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	Property and equipment consists of the following (in thousands):



		September 30,			December 31,
		2014			2013
	Globalstar System:

	Space component

	Second-generation satellites in service	$	1,212,040		$	1,212,099

	Prepaid long-lead items	17,040			17,040

	Second-generation satellite, on-ground spare	32,459			32,365

	Ground component	48,126			48,378

	Construction in progress:

	Space component	11			—

	Ground component	129,489			116,377

	Other	1,811			1,115

	Total Globalstar System	1,440,976			1,427,374

	Internally developed and purchased software	15,794			14,931

	Equipment	12,670			12,385

	Land and buildings	3,719			3,768

	Leasehold improvements	1,662			1,644

	Total property and equipment	1,474,821			1,460,102

	Accumulated depreciation	(354,665		)	(290,317		)
	Total property and equipment, net	$	1,120,156		$	1,169,785

Capitalized Interest	'
	The following tables summarize capitalized interest for the periods indicated below (in thousands):



		Three Months Ended						Nine Months Ended

		September 30, 2014			September 30, 2013			September 30, 2014			September 30, 2013
	Interest cost eligible to be capitalized	$	10,508		$	13,119		$	34,123		$	38,851

	Interest cost recorded in interest expense, net	(8,557		)	(10,151		)	(28,365		)	(24,302		)
	Net interest capitalized	$	1,951		$	2,968		$	5,758		$	14,549

Depreciation Expense	'
	The following table summarizes depreciation expense for the periods indicated below (in thousands):



		Three Months Ended						Nine Months Ended
		September 30, 2014			September 30, 2013			September 30, 2014			September 30, 2013
	Depreciation Expense	$	20,653		$	23,931		$	65,040		$	65,622

LongTerm_Debt_and_Other_Financ1

Long-Term Debt and Other Financing Arrangements (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt	'
	Long-term debt consists of the following (in thousands):



		September 30, 2014							31-Dec-13
		Principal			Carrying				Principal				Carrying
		Amount			Value				Amount				Value
	Facility Agreement	$	586,342		$	586,342			$	586,342			$	586,342

	Thermo Loan Agreement	66,106			30,307				60,383				22,854

	8.00% Convertible Senior Notes Issued in 2013	23,032			14,392				46,971				26,291

	8.00% Convertible Senior Unsecured Notes Issued in 2009	—			—				51,652				33,795

	Total Debt	675,480			631,041				745,348				669,282

	Less: Current Portion	7,271			7,271				4,046				4,046

	Long-Term Debt	$	668,209		$	623,770			$	741,302			$	665,236

Summary of Warrants Outstanding	'
	As a result of the Company’s financing arrangements described above, as of September 30, 2014 and December 31, 2013, warrants were outstanding to purchase 45.1 million and 93.5 million shares, respectively, of the Company’s common stock as shown in the table below:



		Outstanding Warrants					Strike Price
		September 30,		December 31,			September 30,				December 31,
		2014		2013			2014				2013
	Contingent Equity Agreement (1)	37,088,418		41,467,980			$	0.01			$	0.01

	Thermo Loan Agreement (2)	—		4,205,608			—				0.01

	5.0% Notes (3)	8,000,000		8,000,000			0.32				0.32

	8.00% Notes Issued in 2009 (4)	—		39,842,813			—				0.32

		45,088,418		93,516,401



	-1	Pursuant to the terms of the Contingent Equity Agreement, the Company has issued to Thermo warrants to purchase shares of common stock pursuant to the annual availability fee and subsequent reset provisions in the Contingent Equity Agreement. These warrants have a five-year exercise period from issuance. These warrants were issued between June 2009 and June 2012, and the exercise periods expire between June 2014 and June 2017. As of September 30, 2014, Thermo had exercised warrants to purchase approximately 4.4 million of these shares prior to the expiration of the associated warrants.

	-2	As consideration for the Loan Agreement with Thermo, the Company issued Thermo warrants to purchase shares of common stock. The exercise period of the warrants issued in connection with the Thermo Loan Agreement was five years from issuance, which expired in June 2014. Thermo exercised all of these warrants in the second quarter of 2014.

	-3	The 5.0% Warrants are exercisable until June 2016, which is five years after their issuance.

	-4	The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014. All 8.00% Warrants were exercised in the second quarter of 2014.

Derivatives_Tables

Derivatives (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule of Fair Values of Derivative Instruments	'
	The following tables disclose the fair values and classification of the derivative instruments on the Company’s condensed consolidated balance sheets (in thousands):



		September 30,			31-Dec-13
		2014
	Intangible and other assets:

	Interest rate cap	$	72		$	185

	Total intangible and other assets	$	72		$	185

	Derivative liabilities, current:

	Warrants issued with 8.00% Notes Issued in 2009	$	—		$	(57,048	)

	Derivative liabilities, non-current:

	Compound embedded derivative with 8.00% Notes Issued in 2009	$	—		$	(66,022	)

	Compound embedded derivative with 8.00% Notes Issued in 2013	(109,896		)	(109,794		)
	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(465,907		)	(229,662		)
	Total derivative liabilities, non-current:	(575,803		)	(405,478		)
	Total derivative liabilities, current and non-current	$	(575,803	)	$	(462,526	)
Schedule of Derivative Gains (Losses)	'
	The following table discloses the changes in value during the three and nine months ended September 30, 2014 and 2013 recorded as derivative gain (loss) on the Company’s condensed consolidated statement of operations (in thousands):



		Three Months Ended
		September 30, 2014			September 30, 2013
	Interest rate cap	$	(7	)	$	(30	)
	Warrants issued with 8.00% Notes Issued in 2009	—			(6,323		)

	Compound embedded derivative with 8.00% Notes Issued in 2009	—			(29,986		)

	Contingent put feature embedded in the 5.0% Convertible Senior Notes	—			848

	Compound embedded derivative with 8.00% Notes Issued in 2013	43,050			(25,590		)

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	123,946			(36,453		)

	Total derivative gain (loss)	$	166,989		$	(97,534	)




		Nine Months Ended
		September 30, 2014			September 30, 2013
	Interest rate cap	$	(113	)	$	86

	Warrants issued with 8.00% Notes Issued in 2009	(67,523		)	(28,949		)
	Compound embedded derivative with 8.00% Notes Issued in 2009	(16,406		)	(37,233		)
	Contingent put feature embedded in the 5.0% Convertible Senior Notes	—			2,133

	Compound embedded derivative with 8.00% Notes Issued in 2013	(98,376		)	(26,495		)
	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(236,245		)	(36,453		)
	Total derivative loss	$	(418,663	)	$	(126,911	)

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013 (in thousands):



		Fair Value Measurements at September 30, 2014:
		(Level 1)				(Level 2)				(Level 3)				Total
														Balance
	Assets:

	Interest rate cap	$	—			$	72			$	—			$	72

	Total assets measured at fair value	$	—			$	72			$	—			$	72

	Liabilities:

	Derivative Liabilities:

	Compound embedded derivative with 8.00% Notes Issued in 2013	$	—			$	—			(109,896		)		$	(109,896	)

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—				—				(465,907		)		(465,907		)

	Total Derivative Liabilities	—				—				(575,803		)		(575,803		)

	Current Liabilities:

	Liability for contingent consideration	—				—				(1,149		)		(1,149		)

	Total liabilities measured at fair value	$	—			$	—			$	(576,952	)		$	(576,952	)




		Fair Value Measurements at December 31, 2013:
		(Level 1)				(Level 2)				(Level 3)				Total
														Balance
	Assets:

	Interest rate cap	$	—			$	185			$	—			$	185

	Total assets measured at fair value	$	—			$	185			$	—			$	185

	Liabilities:

	Derivative Liabilities:

	Warrants issued with 8.00% Notes Issued in 2009	$	—			$	—			$	(57,048	)		$	(57,048	)

	Compound embedded derivative with 8.00% Notes Issued in 2009	—				—				(66,022		)		(66,022		)

	Compound embedded derivative with 8.00% Notes Issued in 2013	—				—				(109,794		)		(109,794		)

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—				—				(229,662		)		(229,662		)

	Total Derivative Liabilities	—				—				(462,526		)		(462,526		)

	Current Liabilities:

	Liability for contingent consideration	—				—				(1,923		)		(1,923		)

	Total liabilities measured at fair value	$	—			$	—			$	(464,449	)		$	(464,449	)

Schedule of Significant Quantitative Level 3 Inputs Utilized	'
	The significant quantitative Level 3 inputs utilized in the valuation models as of September 30, 2014 and December 31, 2013 are shown in the tables below:



		Level 3 Inputs at September 30, 2014:
		Stock Price		Risk-Free			Note				Warrant		Market Price of Common Stock
		Volatility		Interest			Conversion				Exercise
				Rate			Price				Price
	Compound embedded derivative with 8.00% Notes Issued in 2013	65% - 95%		1.3	%		$	0.73			N/A		$	3.66

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	50% - 90%		2.4	%		$	0.73			N/A		$	3.66




		Level 3 Inputs at December 31, 2013:
		Stock Price			Risk-Free			Note				Warrant				Market Price of Common Stock
		Volatility			Interest			Conversion				Exercise
					Rate			Price				Price
	Compound embedded derivative with 8.00% Notes Issued in 2009	65% - 100%			1.5	%		$	1.14			N/A				$	1.75

	Warrants issued with 8.00% Notes Issued in 2009	100	%		0.1	%		N/A				$	0.32			$	1.75

	Compound embedded derivative with 8.00% Notes Issued in 2013	65% - 100%			1.5	%		$	0.73			N/A				$	1.75

	Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	65% - 100%			3	%		$	0.73			N/A				$	1.75

Reconciliation of Liabilities Measured at Fair Value on Recurring Basis	'
	The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2014 as follows (in thousands):



	Balance at June 30, 2014	$	(775,361	)
	Earnout payments made related to liability for contingent consideration	585

	Change in fair value of contingent consideration	(189		)
	Derivative adjustment related to conversions and exercises	31,017

	Unrealized gain, included in derivative gain (loss)	166,996

	Balance at September 30, 2014	$	(576,952	)



	Balance at December 31, 2013	$	(464,449	)
	Earnout payments made related to liability for contingent consideration	1,583

	Change in fair value of contingent consideration	(809		)
	Derivative adjustment related to conversions and exercises	305,274

	Unrealized loss, included in derivative gain (loss)	(418,551		)
	Balance at September 30, 2014	$	(576,952	)

Accrued_Expenses_and_NonCurren1

Accrued Expenses and Non-Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
Schedule of Accrued Expenses	'
	Accrued expenses consist of the following (in thousands):



		September 30,		December 31,
		2014		2013
	Accrued interest	$	5,750	$	1,200

	Accrued compensation and benefits	2,552		3,927

	Accrued property and other taxes	5,366		5,744

	Accrued customer liabilities and deposits	2,822		2,663

	Accrued professional and other service provider fees	1,826		705

	Accrued liability for contingent consideration	1,149		1,922

	Accrued commissions	974		1,316

	Accrued telecommunications expenses	918		649

	Accrued second-generation constellation costs	1,887		—

	Other accrued expenses	2,622		4,574

	Total accrued expenses	$	25,866	$	22,700

Schedule of Other Non-current Liabilities	'
	Noncurrent liabilities consist of the following (in thousands):



		September 30,		December 31,
		2014		2013
	Long-term accrued interest	$	259	$	451

	Asset retirement obligation	1,158		1,083

	Deferred rent and capital lease obligations	433		456

	Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,594		1,575

	Uncertain income tax positions	6,704		5,918

	Foreign tax contingencies	3,839		4,213

	Total noncurrent liabilities	$	13,987	$	13,696

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Thermo incurs certain expenses on behalf of the Company. The table below summarizes the total expense for the periods indicated below (in thousands):



		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	General and administrative expenses	$	174	$	74	$	236	$	229

	Non-cash expenses	137		137		411		411

	Loss on equity issuance	—		2,404		—		16,373

	Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	—		66,088		—		$	66,088

	Total	$	311	$	68,703	$	647	$	83,101

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'
Components of Accumulated Other Comprehensive Loss	'
	The components of accumulated other comprehensive income (loss) were as follows (in thousands):



		Three Months Ended September 30,						Nine Months Ended September 30,
		2014			2013			2014			2013
	Accumulated other comprehensive income (loss), June 30, 2014 and 2013 and December 31, 2013 and 2012, respectively	$	493		$	(2,408	)	$	871		$	(1,758	)

	Other comprehensive income (loss) :

	Foreign currency translation adjustments	(493		)	553			(871		)	(97		)

	Accumulated other comprehensive income (loss), September 30, 2014 and 2013, respectively	$	—		$	(1,855	)	$	—		$	(1,855	)

Stock_Compensation_Tables

Stock Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Grants to Eligible Participants of Incentive Stock Options, Restricted Stock Awards, and Restricted Stock Units	'
	Grants to Eligible Participants of incentive stock options, restricted stock awards, and restricted stock units during the period are indicated in the table below (in thousands):



		Three Months Ended September 30,		Nine Months Ended September 30,
		2014	2013	2014	2013
	Grants of restricted stock awards and restricted stock units	201	14	607	852

	Grants of options to purchase common stock	134	1,224	595	1,829

	Total	335	1,238	1,202	2,681

Geographic_Information_Tables

Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Company's Information on Revenues and Long-lived Assets by Geographic Area	'
	The Company’s information by geographic area is as follows (in thousands):



		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Revenues:

	Service:

	United States	$	12,267	$	11,660	$	35,000	$	33,666

	Canada	4,077		3,446		10,946		9,123

	Europe	1,655		1,185		4,407		2,736

	Central and South America	440		625		1,886		1,918

	Others	72		140		408		411

	Total service revenue	$	18,511	$	17,056	$	52,647	$	47,854

	Subscriber equipment:

	United States	2,510		3,688		8,340		8,756

	Canada	1,418		1,201		4,187		2,964

	Europe	540		327		1,628		1,228

	Central and South America	437		177		930		712

	Others	25		100		239		203

	Total subscriber equipment revenue	$	4,930	$	5,493	$	15,324	$	13,863

	Total revenue	$	23,441	$	22,549	$	67,971	$	61,717




		September 30,		December 31,
		2014		2013
	Long-lived assets:

	United States	$	1,114,934	$	1,164,358

	Canada	318		247

	Europe	470		408

	Central and South America	3,510		3,595

	Others	924		1,177

	Total long-lived assets	$	1,120,156	$	1,169,785

Earning_Loss_Per_Share_Tables

Earning (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Reconciliation of Basic Weighted Average Share to Diluted Weighted Average Common Shares Outstanding	'
	The following table reconciles basic weighted average common shares to diluted weighted average common shares outstanding for the three months ended September 30, 2014 (in thousands):



		Three Months Ended September 30, 2014
	Weighted average common shares outstanding:
	Basic shares outstanding	987,668

	Incremental shares from assumed exercises of:
	Stock options, restricted stock, restricted stock units and ESPP	7,340

	8% Convertible Senior Notes Issued in 2013	39,625

	Thermo Loan Agreement	109,469

	Warrants	45,088

	Diluted shares outstanding	1,189,190

Supplemental_Condensed_Consoli1

Supplemental Condensed Consolidating Financial Information (Tables)	9 Months Ended
	Sep. 30, 2014
SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]	'
Supplemental Condensed Consolidating Statement of Operations	'
	Globalstar, Inc.
	Supplemental Condensed Consolidating Statement of Operations
	Three Months Ended September 30, 2014
	(Unaudited)



		Parent				Guarantor				Non-				Eliminations				Consolidated
		Company				Subsidiaries				Guarantor
										Subsidiaries
		(In thousands)
	Revenues:

	Service revenues	$	19,258			$	1,494			$	6,389			$	(8,630	)		$	18,511

	Subscriber equipment sales	71				3,471				5,118				(3,730		)		4,930

	Total revenue	19,329				4,965				11,507				(12,360		)		23,441

	Operating expenses:

	Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	2,903				2,653				2,563				(251		)		7,868

	Cost of subscriber equipment sales	31				2,962				4,823				(3,980		)		3,836

	Cost of subscriber equipment sales - reduction in the value of inventory	—				—				—				—				—

	Marketing, general and administrative	1,906				3,850				4,408				(1,381		)		8,783

	Depreciation, amortization, and accretion	19,180				1,879				6,974				(6,986		)		21,047

	Total operating expenses	24,020				11,344				18,768				(12,598		)		41,534

	Loss from operations	(4,691		)		(6,379		)		(7,261		)		238				(18,093		)

	Other income (expense):

	Loss on extinguishment of debt	(12,936		)		—				—				—				(12,936		)

	Interest income and expense, net of amounts capitalized	(9,001		)		(10		)		(57		)		1				(9,067		)

	Derivative gain	166,989				—				—				—				166,989

	Equity in subsidiary earnings	(12,653		)		(884		)		—				13,537				—

	Other	1,782				409				364				31				2,586

	Total other income (expense)	134,181				(485		)		307				13,569				147,572

	Income (loss) before income taxes	129,490				(6,864		)		(6,954		)		13,807				129,479

	Income tax expense	100				7				(18		)		—				89

	Net income (loss)	$	129,390			$	(6,871	)		$	(6,936	)		$	13,807			$	129,390

	Comprehensive income (loss)	$	129,390			$	(6,871	)		$	(7,430	)		$	13,807			$	128,896


	Globalstar, Inc.
	Supplemental Condensed Consolidating Statement of Operations
	Three Months Ended September 30, 2013
	(Unaudited)


	Parent				Guarantor				Non-				Eliminations				Consolidated
	Company				Subsidiaries				Guarantor
									Subsidiaries
	(In thousands)
Revenues:

Service revenues	$	18,726			$	2,478			$	4,940			$	(9,088	)		$	17,056

Subscriber equipment sales	127				4,254				1,070				42				5,493

Total revenue	18,853				6,732				6,010				(9,046		)		22,549

Operating expenses:

Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	3,125				3,126				1,941				(11		)		8,181

Cost of subscriber equipment sales	90				3,334				1,819				(1,095		)		4,148

Marketing, general and administrative	2,008				4,666				3,774				(1,369		)		9,079

Depreciation, amortization, and accretion	19,645				4,914				6,485				(7,329		)		23,715

Total operating expenses	24,868				16,040				14,019				(9,804		)		45,123

Loss from operations	(6,015		)		(9,308		)		(8,009		)		758				(22,574		)

Other income (expense):

Loss on extinguishment of debt	(63,569		)		—				—				—				(63,569		)

Loss on equity issuance	(2,733		)		—				—				—				(2,733		)

Interest income and expense, net of amounts capitalized	(16,636		)		(3		)		(262		)		—				(16,901		)

Derivative loss	(97,534		)		—				—				—				(97,534		)

Equity in subsidiary earnings	(17,090		)		(1,729		)		—				18,819				—

Other	(1,343		)		(171		)		(21		)		(5		)		(1,540		)
Total other income (expense)	(198,905		)		(1,903		)		(283		)		18,814				(182,277		)

Loss before income taxes	(204,920		)		(11,211		)		(8,292		)		19,572				(204,851		)

Income tax expense	49				6				63				—				118

Net (loss) income	$	(204,969	)		$	(11,217	)		$	(8,355	)		$	19,572			$	(204,969	)

Comprehensive (loss) income	$	(204,969	)		$	(11,217	)		$	(7,803	)		$	19,572			$	(204,417	)



Supplemental Condensed Consolidating Balance Sheet	'
	Globalstar, Inc.
	Supplemental Condensed Consolidating Balance Sheet
	As of September 30, 2014
	(Unaudited)



		Parent				Guarantor				Non-Guarantor				Elimination				Consolidated
		Company				Subsidiaries				Subsidiaries
		(In thousands)
	ASSETS

	Current assets:

	Cash and cash equivalents	$	22,921			$	912			$	3,388			$	—			$	27,221

	Accounts receivable	4,582				6,151				5,227				257				16,217

	Intercompany receivables	727,100				436,281				23,711				(1,187,092		)		—

	Inventory	4,122				12,419				12,736				—				29,277

	Advances for inventory	125				28				43				—				196

	Prepaid expenses and other current assets	4,374				278				2,804				—				7,456

	Total current assets	763,224				456,069				47,909				(1,186,835		)		80,367

	Property and equipment, net	1,111,237				3,697				6,277				(1,055		)		1,120,156

	Restricted cash	37,918				—				—				—				37,918

	Intercompany notes receivable	13,006				—				4,885				(17,891		)		—

	Investment in subsidiaries	(241,579		)		4,216				29,382				207,981				—

	Deferred financing costs	66,816				—				—				—				66,816

	Intangible and other assets, net	11,999				671				2,047				(14		)		14,703

	Total assets	$	1,762,621			$	464,653			$	90,500			$	(997,814	)		$	1,319,960

	LIABILITIES AND
	STOCKHOLDERS’ EQUITY
	Current liabilities:

	Current portion of long-term debt	$	7,271			$	—			$	—			$	—			$	7,271

	Accounts payable	8,112				2,045				2,038				—				12,195

	Accrued contract termination charge	22,238				—				—				—				22,238

	Accrued expenses	11,122				7,195				7,549				—				25,866

	Intercompany payables	492,868				552,218				144,152				(1,189,238		)		—

	Payables to affiliates	443				—				—				—				443

	Deferred revenue	2,885				16,092				3,214				—				22,191

	Total current liabilities	544,939				577,550				156,953				(1,189,238		)		90,204

	Long-term debt, less current portion	623,770				—				—				—				623,770

Employee benefit obligations	3,147				—				(1		)		—				3,146

Intercompany notes payable	—				—				15,448				(15,448		)		—

Derivative liabilities	575,803				—				—				—				575,803

Deferred revenue	6,330				457				—				—				6,787

Debt restructuring fees	20,795				—				—				—				20,795

Other non-current liabilities	2,369				293				11,325				—				13,987

Total non-current liabilities	1,232,214				750				26,772				(15,448		)		1,244,288

Stockholders’ equity	(14,532		)		(113,647		)		(93,225		)		206,872				(14,532		)

Total liabilities and stockholders’ equity	$	1,762,621			$	464,653			$	90,500			$	(997,814	)		$	1,319,960


Globalstar, Inc.
Supplemental Condensed Consolidating Balance Sheet
As of December 31, 2013
(Audited)



	Parent				Guarantor				Non-Guarantor				Elimination				Consolidated
	Company				Subsidiaries				Subsidiaries
	(In thousands)
ASSETS

Current assets:

Cash and cash equivalents	$	12,935			$	676			$	3,797			$	—			$	17,408

Accounts receivable	5,925				5,022				4,602				174				15,723

Intercompany receivables	651,251				414,508				18,280				(1,084,039		)		—

Inventory	1,161				14,375				16,281				—				31,817

Advances for inventory	9,287				28				44				—				9,359

Prepaid expenses and other current assets	4,316				311				2,432				—				7,059

Total current assets	684,875				434,920				45,436				(1,083,865		)		81,366

Property and equipment, net	1,152,734				11,621				6,889				(1,459		)		1,169,785

Restricted cash	37,918				—				—				—				37,918

Intercompany notes receivable	13,629				—				4,285				(17,914		)		—

Investment in subsidiaries	(209,592		)		7,242				—				202,350				—

Deferred financing costs	76,436				—				—				—				76,436

Intangible and other assets, net	3,964				1,028				2,125				(14		)		7,103

Total assets	$	1,759,964			$	454,811			$	58,735			$	(900,902	)		$	1,372,608

LIABILITIES AND
STOCKHOLDERS’ EQUITY
Current liabilities:

Current portion of long-term debt	$	4,046			$	—			$	—			$	—			4,046

Accounts payable	9,906				2,041				2,680				—				14,627

Accrued contract termination charge	24,133				—				—				—				24,133

Accrued expenses	6,160				8,203				8,337				—				22,700

Intercompany payables	435,707				521,763				128,496				(1,085,966		)		—

Payables to affiliates	202				—				—				—				202

Derivative liabilities	57,048				—				—				—				57,048

Deferred revenue	1,843				13,094				2,347				—				17,284

Total current liabilities	539,045				545,101				141,860				(1,085,966		)		140,040

Long-term debt, less current portion	665,236				—				—				—				665,236

Employee benefit obligations	3,529				—				—				—				3,529

Intercompany notes payable	—				—				15,772				(15,772		)		—

Derivative liabilities	405,478				—				—				—				405,478

Deferred revenue	6,583				496				—				—				7,079

Debt restructuring fees	20,795				—				—				—				20,795

Other non-current liabilities	2,543				297				10,856				—				13,696

Total non-current liabilities	1,104,164				793				26,628				(15,772		)		1,115,813

Stockholders’ equity	116,755				(91,083		)		(109,753		)		200,836				116,755

Total liabilities and stockholders’ equity	$	1,759,964			$	454,811			$	58,735			$	(900,902	)		$	1,372,608

Supplemental Condensed Consolidating Statement of Cash Flows	'
	Globalstar, Inc.
	Supplemental Condensed Consolidating Statement of Cash Flows
	Nine Months Ended September 30, 2014
	(Unaudited)



		Parent				Guarantor				Non-				Eliminations				Consolidated
		Company				Subsidiaries				Guarantor
										Subsidiaries
		(In thousands)
	Net cash provided by (used in) operating activities	$	6,066			$	728			$	81			$	—			$	6,875

	Cash flows from investing activities:

	Second-generation satellites, ground and related launch costs	(3,862		)		—				—				—				(3,862		)

	Property and equipment additions	(1,357		)		(492		)		(354		)		—				(2,203		)

	Net cash used in investing activities	(5,219		)		(492		)		(354		)		—				(6,065		)

	Cash flows provided by (used in) financing activities:

	Proceeds from issuance of common stock and exercise of warrants	9,303				—				—				—				9,303

	Payment of deferred financing costs	(164		)		—				—				—				(164		)

	Net cash used in financing activities	9,139				—				—				—				9,139

	Effect of exchange rate changes on cash and cash equivalents	—				—				(136		)		—				(136		)

	Net increase (decrease) in cash and cash equivalents	9,986				236				(409		)		—				9,813

	Cash and cash equivalents at beginning of period	12,935				676				3,797				—				17,408

	Cash and cash equivalents at end of period	$	22,921			$	912			$	3,388			$	—			$	27,221


	Globalstar, Inc.
	Supplemental Condensed Consolidating Statement of Cash Flows
	Nine Months Ended September 30, 2013
	(Unaudited)



		Parent				Guarantor				Non-				Eliminations				Consolidated
		Company				Subsidiaries				Guarantor
										Subsidiaries
		(In thousands)
	Net cash provided used in operating activities	$	426			$	814			$	1,094			$	—			$	2,334

	Cash flows from investing activities:

	Second-generation satellites, ground and related launch costs	(37,732		)		—				—				—				(37,732		)

	Property and equipment additions	—				(706		)		(519		)		—				(1,225		)

	Investment in businesses	(496		)		—				—				—				(496		)

	Restricted cash	8,838				—				—				—				8,838

	Net cash from investing activities	(29,390		)		(706		)		(519		)		—				(30,615		)

Cash flows from financing activities:

Borrowings from Facility Agreement	672																672

Borrowings from contingent equity account	1,071																1,071

Proceeds from issuance of common stock and stock options	8,979				—				—				—				8,979

Payments to reduce principal amount of exchanged 5.75% Notes	(13,544		)		—				—				—				(13,544		)

Payments to reduce principal amount of 5.75% Notes not exchanged	(6,250		)		—				—				—				(6,250		)

Payments to lenders and other fees associated with exchange	(2,482		)		—				—				—				(2,482		)

Proceeds from equity issuance to related party	51,500				—				—				—				51,500

Payment of deferred financing costs	(16,904		)		—				—				—				(16,904		)

Net cash used in financing activities	23,042				—				—				—				23,042

Effect of exchange rate changes on cash and cash equivalents	—				—				90				—				90

Net increase (decrease) in cash and cash equivalents	(5,922		)		108				665				—				(5,149		)

Cash and cash equivalents at beginning of period	10,220				251				1,321				—				11,792

Cash and cash equivalents at end of period	$	4,298			$	359			$	1,986			$	—			$	6,643

Schedule_of_Property_and_Equip

Schedule of Property and Equipment (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$1,474,821	$1,460,102
Accumulated depreciation and amortization	-354,665	-290,317
Property, Plant and Equipment, Net, Total	1,120,156	1,169,785
Internally Developed and Purchased Software	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	15,794	14,931
Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	12,670	12,385
Land and Buildings	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	3,719	3,768
Leasehold Improvements	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	1,662	1,644
Global Star System	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	1,440,976	1,427,374
Global Star System \| Space Component	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	48,126	48,378
Global Star System \| Second-generation satellites in service \| Space Component	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	1,212,040	1,212,099
Global Star System \| Prepaid long-lead items \| Space Component	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	17,040	17,040
Global Star System \| Second-generation satellite, on-ground spare \| Space Component	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	32,459	32,365
Global Star System \| Construction in Progress \| Space Component	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	11	'
Global Star System \| Construction in Progress \| Ground Component	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	129,489	116,377
Global Star System \| Construction in Progress \| Other	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$1,811	$1,115

Capitalized_Interest_and_Depre

Capitalized Interest and Depreciation Expense (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Interest Costs Incurred [Abstract]	'	'	'	'
Interest cost eligible to be capitalized	$10,508	$13,119	$34,123	$38,851
Interest cost recorded in interest expense, net	-8,557	-10,151	-28,365	-24,302
Net interest capitalized	1,951	2,968	5,758	14,549
Depreciation Expense	$20,653	$23,931	$65,040	$65,622

Schedule_of_Longterm_Debt_Deta

Schedule of Long-term Debt (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	20-May-13
Principal Amount	'	'	'
Total Debt	$675,480,000	$745,348,000	'
Less: Current Portion	7,271,000	4,046,000	'
Long-Term Debt	668,209,000	741,302,000	'
Carrying Value	'	'	'
Total Debt	631,041,000	669,282,000	'
Less: Current Portion	7,271,000	4,046,000	'
Long-Term Debt	623,770,000	665,236,000	'
Facility Agreement	'	'	'
Principal Amount	'	'	'
Total Debt	586,342,000	586,342,000	'
Carrying Value	'	'	'
Total Debt	586,342,000	586,342,000	'
Thermo Loan Agreement	'	'	'
Principal Amount	'	'	'
Total Debt	66,106,000	60,383,000	'
Carrying Value	'	'	'
Total Debt	30,307,000	22,854,000	'
8.00% Convertible Senior Notes Issued in 2013	'	'	'
Principal Amount	'	'	'
Total Debt	23,032,000	46,971,000	54,600,000
Carrying Value	'	'	'
Total Debt	14,392,000	26,291,000	'
8.00% Convertible Senior Unsecured Notes Issued in 2009	'	'	'
Principal Amount	'	'	'
Total Debt	0	51,652,000	'
Carrying Value	'	'	'
Total Debt	$0	$33,795,000	'

Facility_Agreement_Details

Facility Agreement (Details) (Facility Agreement, USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Debt Instrument [Line Items]	'
Interest above LIBOR rate	2.75%
Percentage of guarantee provided by French export credit agency to lending syndicate	95.00%
Debt service reserve account	$37.90
Domestic Subsidiaries	'
Debt Instrument [Line Items]	'
Percentage of equity pledged as collateral	100.00%
Foreign Subsidiaries	'
Debt Instrument [Line Items]	'
Percentage of equity pledged as collateral	65.00%
Minimum	'
Debt Instrument [Line Items]	'
Interest rate increase	0.50%
Maximum	'
Debt Instrument [Line Items]	'
Interest rate increase	5.75%

Thermo_Loan_Agreement_Details

Thermo Loan Agreement (Details) (Thermo, USD $)	9 Months Ended
Thermo Loan Agreement (Details) (Thermo, USD $)	Sep. 30, 2014	Dec. 31, 2011	Jun. 30, 2009
Debt Instrument [Line Items]	'	'	'
Maximum borrowing capacity	$37,500,000	'	'
Thermo Loan Agreement	'	'	'
Debt Instrument [Line Items]	'	'	'
Maximum borrowing capacity	'	37,500,000	25,000,000
Loan interest rate	12.00%	'	'
Maturity period after full payment of Facility Agreement	'6 months	'	'
Outstanding interest	$28,600,000	'	'

800_Convertible_Senior_Notes_I

8.00% Convertible Senior Notes Issued in 2013 (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

13 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

20-May-13

Mar. 20, 2014

Jul. 19, 2013

20-May-13

Sep. 30, 2014

Jun. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

20-May-13

5.75% Convertible Senior Unsecured Notes

8.00% Convertible Senior Notes Issued in 2013

Debt Instrument [Line Items]

Percentage of principal redeemed in exchange agreement

91.50%

Interest rate, payable in cash

5.75%

Debt

$675,480,000

$745,348,000

$23,032,000

$46,971,000

$54,600,000

Loan interest rate

8.00%

Loss on extinguishment of debt

12,936,000

63,569,000

47,200,000

39,615,000

110,809,000

43,800,000

Conversion price per share of common stock (USD per share)

$0.73

$0.80

Number of shares of common stock convertible into (shares)

1,250

Principal converted

$76,040,000

$23,570,000

$7,000,000

$1,000

$32,400,000

Interest rate, payable in additional notes

2.25%

Maturity date

1-Apr-28

Percentage of debt that is convertible

15.00%

Price trigger for convertibility

$0.50

Percentage of principal converted

15.00%

12.90%

Conversion of notes into shares of common stock

14,600,000

14,300,000

59,500,000

800_Convertible_Senior_Notes_I1

8.00% Convertible Senior Notes Issued in 2009 (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Apr. 15, 2014

Sep. 30, 2014

Dec. 31, 2013

20-May-13

Jun. 30, 2009

8.00% Convertible Senior Unsecured Notes Issued in 2009

Debt Instrument [Line Items]

Aggregate principal amount convertible notes maximum borrowing capacity

$55,000,000

Convertible notes stated interest rate

8.00%

Number of common stock shares to be purchased (in shares)

45,088,418

93,516,401

[1]

39,842,813

[1]

15,300,000

Warrants exercised associated with conversion of notes (shares)

38,200,000

Proceeds from warrant exercises

7,500,000

Convertible debt, percentage of stock price trigger

200.00%

Convertible debt, consecutive trading days threshold

'30 days

Debt conversion amount

37,800,000

Conversion of notes into shares of common stock

34,500,000

Exercise price of warrants (USD per warrant)

0.32

[1]

0.32

[1]

Conversion price per share of common stock (USD per share)

$1.14

Gain on extinguishment of debt

($12,936,000)

($63,569,000)

($47,200,000)

($39,615,000)

($110,809,000)

$4,300,000

[1]

The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014. All 8.00% Warrants were exercised in the second quarter of 2014.

Warrants_Outstanding_Details

Warrants Outstanding (Details)

0 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

3 Months Ended

20-May-13

21-May-13

Jun. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Apr. 15, 2014

Dec. 31, 2013

20-May-13

Jun. 30, 2009

Thermo

Contingent Equity Agreement

Thermo Loan Agreement

5.00% Convertible Senior Unsecured Notes

8.00% Convertible Senior Unsecured Notes Issued in 2009

Thermo

Class of Warrant or Right [Line Items]

Warrants outstanding (warrants)

45,088,418

93,516,401

37,088,418

[1]

41,467,980

[1]

[2]

4,205,608

[2]

8,000,000

[3]

8,000,000

[3]

[4]

39,842,813

[4]

15,300,000

Exercise price of warrants (USD per warrant)

0.01

[1]

0.01

[1]

[2]

0.01

[2]

0.32

[3]

0.32

[3]

[4]

0.32

[4]

Expiration period

'5 years

Number of warrants exercised (in warrants)

78,125,000

15,625,000

28,125,000

121,900,000

4,400,000

4,200,000

14,700,000

Loan interest rate

12.00%

5.00%

8.00%

[1]

Pursuant to the terms of the Contingent Equity Agreement, the Company has issued to Thermo warrants to purchase shares of common stock pursuant to the annual availability fee and subsequent reset provisions in the Contingent Equity Agreement. These warrants have a five-year exercise period from issuance. These warrants were issued between June 2009 and June 2012, and the exercise periods expire between June 2014 and June 2017. As of SeptemberB 30, 2014, Thermo had exercised warrants to purchase approximately 4.4 million of these shares prior to the expiration of the associated warrants.

[2]

As consideration for the Loan Agreement with Thermo, the Company issued Thermo warrants to purchase shares of common stock. The exercise period of the warrants issued in connection with the Thermo Loan Agreement was five years from issuance, which expired in June 2014. Thermo exercised all of these warrants in the second quarter of 2014.

[3]

The 5.0% Warrants are exercisable until June 2016, which is five years after their issuance.

[4]

The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014. All 8.00% Warrants were exercised in the second quarter of 2014.

Consent_Agreement_Details

Consent Agreement (Details) (USD $)

0 Months Ended

1 Months Ended

12 Months Ended

13 Months Ended

0 Months Ended

20-May-13

21-May-13

Aug. 31, 2013

Jul. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

20-May-13

Sep. 30, 2014

20-May-13

Nonvoting Common Stock

8.00% Convertible Senior Notes Issued in 2013

Thermo Capital Partners LLC

Scenario One

Scenario Two

Scenario Three

Scenario Four

Debt Instrument [Line Items]

Interest rate, payable in cash

5.75%

Loan interest rate

8.00%

Compensating balance, amount

$4,000,000

Amount of payment in exchange transaction

25,000,000

Amount of third party credit enhancements

20,000,000

40,000,000

Proceeds from common stock

$25,000,000

$5,000,000

$6,500,000

$6,000,000

$9,000,000

$39,000,000

$65,000,000

Number of shares issued (in shares)

78,125,000

15,625,000

28,125,000

121,900,000

171,900,000

Common_Stock_Purchase_Agreemen

Common Stock Purchase Agreement (Details) (USD $)	0 Months Ended		1 Months Ended			3 Months Ended	12 Months Ended	13 Months Ended
Common Stock Purchase Agreement (Details) (USD $)	20-May-13	21-May-13	Aug. 31, 2013	Jul. 31, 2013	Jun. 30, 2013	Sep. 30, 2013	Dec. 31, 2013	Jun. 30, 2014	Dec. 27, 2013	Oct. 14, 2013	20-May-13
Class of Stock [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Number of shares issued (in shares)	78,125,000	15,625,000	'	'	28,125,000	'	121,900,000	'	'	'	'
Proceeds from common stock	$25,000,000	$5,000,000	$6,500,000	$6,000,000	$9,000,000	'	$39,000,000	$65,000,000	'	'	'
Shares issued, price per share (USD per share)	'	'	'	'	'	'	'	'	$0.52	$0.52	$0.32
Loss on sale of shares	'	'	'	'	'	($14,000,000)	'	'	'	'	'
Nonvoting Common Stock	'	'	'	'	'	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Number of shares issued (in shares)	'	'	'	'	'	'	'	171,900,000	'	'	'

The_Common_Stock_Purchase_and_

The Common Stock Purchase and Option Agreement (Details) (USD $)

0 Months Ended

1 Months Ended

3 Months Ended

4 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

Dec. 27, 2013

Oct. 14, 2013

Aug. 31, 2013

Jul. 31, 2013

Sep. 30, 2013

Nov. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

20-May-13

Dec. 31, 2013

Sep. 30, 2013

Dec. 31, 2013

Option One

Option Two

Thermo Capital Partners LLC

Class of Stock [Line Items]

Number of shares issued per option agreement (in shares)

26,000,000

11,538,461

38,461,538

24,000,000

Shares issued, price per share (USD per share)

$0.52

$0.32

Proceeds from equity issuance to related party

$13,500,000

$6,500,000

$6,000,000

$51,500,000

$12,500,000

Value of shares issued per option agreement

20,000,000

13,500,000

11,500,000

Percentage of average closing price

85.00%

Loss on sale of shares

($14,000,000)

($2,400,000)

Terrapin_Opportunity_LP_Common

Terrapin Opportunity, L.P. Common Stock Purchase Agreement (Details) (USD $)	0 Months Ended			1 Months Ended			9 Months Ended	12 Months Ended	13 Months Ended		6 Months Ended
	20-May-13	21-May-13	Dec. 28, 2012	Aug. 31, 2013	Jul. 31, 2013	Jun. 30, 2013	Sep. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Dec. 28, 2012	Jun. 30, 2014
	20-May-13	21-May-13	Dec. 28, 2012	Aug. 31, 2013	Jul. 31, 2013	Jun. 30, 2013	draw_down_notice	Dec. 31, 2013	Jun. 30, 2014	Dec. 28, 2012	Terrapin
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Maximum value of shares required to be purchased per terms of stock purchase agreement	'	'	'	'	'	'	$24,000,000	'	'	$30,000,000	'
Stock Purchase Agreement Term	'	'	'24 months	'	'	'	'	'	'	'	'
Number of draw down notices (in notices)	'	'	'	'	'	'	36	'	'	'	'
Draw down period	'	'	'	'	'	'	'10 days	'	'	'	'
Minimum discount percentage per each share sold under the stock sold agreement	'	'	'	'	'	'	'	'	'	3.50%	'
Maximum discount percentage per each share sold under the stock purchase agreement	'	'	'	'	'	'	'	'	'	8.00%	'
Maximum beneficial ownership percentage allowed per terms of stock purchase agreement	'	'	'	'	'	'	'	'	'	9.90%	'
Number of shares issued (in shares)	78,125,000	15,625,000	'	'	'	28,125,000	'	121,900,000	'	'	6,100,000
Proceeds from common stock	$25,000,000	$5,000,000	'	$6,500,000	$6,000,000	$9,000,000	'	$39,000,000	$65,000,000	'	$6,000,000

Schedule_of_Fair_Value_of_Deri

Schedule of Fair Value of Derivative Instruments (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Derivative assets:	'	'
Intangible and other assets	$72	$185
Derivative liabilities:	'	'
Derivative liabilities, current	0	-57,048
Derivative liabilities, non-current	-575,803	-405,478
Total derivative liabilities, current and non-current	-575,803	-462,526
Interest rate cap	'	'
Derivative assets:	'	'
Intangible and other assets	72	185
Warrants issued with 8.00% Notes Issued in 2009	'	'
Derivative liabilities:	'	'
Derivative liabilities, current	0	-57,048
Compound embedded derivative with 8.00% Notes Issued in 2009	'	'
Derivative liabilities:	'	'
Derivative liabilities, non-current	0	-66,022
Compound embedded derivative with 8.00% Notes Issued in 2013	'	'
Derivative liabilities:	'	'
Derivative liabilities, non-current	-109,896	-109,794
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'
Derivative liabilities:	'	'
Derivative liabilities, non-current	($465,907)	($229,662)

Schedule_of_Derivative_Gain_Lo

Schedule of Derivative Gain (Loss) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	$166,989	($97,534)	($418,663)	($126,911)
Interest rate cap	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	-7	-30	-113	86
Warrants issued with 8.00% Notes Issued in 2009	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	0	-6,323	-67,523	-28,949
Compound embedded derivative with 8.00% Notes Issued in 2009	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	0	-29,986	-16,406	-37,233
Contingent put feature embedded in the 5.0% Convertible Senior Notes	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	0	848	0	2,133
Compound embedded derivative with 8.00% Notes Issued in 2013	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	43,050	-25,590	-98,376	-26,495
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'	'
Derivative gain (loss)	$123,946	($36,453)	($236,245)	($36,453)

Derivatives_Details

Derivatives (Details) (USD $)	Sep. 30, 2014	20-May-13	Jun. 30, 2009	Sep. 30, 2013	20-May-13	Sep. 30, 2014	Jun. 30, 2009	Jun. 30, 2009	Jun. 30, 2009	Jun. 30, 2009
In Millions, unless otherwise specified	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Notes Issued in 2013	8.00% Convertible Senior Notes Issued in 2013	5.00% Convertible Senior Unsecured Notes	Interest rate cap	Interest rate cap	Interest rate cap	Interest rate cap
							contracts	Minimum	Maximum	Six-month LIBOR Rate
Derivative [Line Items]	'	'	'	'	'	'	'	'	'	'
Number of Interest rate cap agreements (in contracts)	'	'	'	'	'	'	5	'	'	'
Maturity period	'	'	'	'	'	'	'10 years	'	'	'
Interest cap rate notional amount	'	'	'	'	'	'	'	$14.80	$586.30	'
Base rate to be capped, should the Base Rate not exceed 6.50%	'	'	'	'	'	'	'	'	'	5.50%
Interest on outstanding amounts on the Facility Agreement	'	'	'	'	'	'	'	'	'	6.50%
Base rate to be lowered from LIBOR, should the base rate exceed 6.50%	'	'	'	'	'	'	'	'	'	1.00%
Fee for interest rate cap agreements	'	'	'	'	'	'	'	'	'	$12.40
Loan interest rate	8.00%	8.00%	8.00%	8.00%	8.00%	5.00%	'	'	'	'

Financial_Assets_and_Liabiliti

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate cap	$72	$185
Total derivative liabilities, current and non-current	-575,803	-462,526
Interest rate cap	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate cap	72	185
Fair Value, Measurements, Recurring	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total assets measured at fair value	72	185
Total derivative liabilities, current and non-current	-575,803	-462,526
Liability for contingent consideration	-1,149	-1,923
Total liabilities measured at fair value	-576,952	-464,449
Fair Value, Measurements, Recurring \| Interest rate cap	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate cap	72	185
Fair Value, Measurements, Recurring \| Warrants issued with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	-57,048
Fair Value, Measurements, Recurring \| Compound embedded derivative with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	-66,022
Fair Value, Measurements, Recurring \| Compound embedded derivative with 8.00% Notes Issued in 2013	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	-109,896	-109,794
Fair Value, Measurements, Recurring \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	-465,907	-229,662
Fair Value, Measurements, Recurring \| (Level 1)	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total assets measured at fair value	0	0
Total derivative liabilities, current and non-current	0	0
Liability for contingent consideration	0	0
Total liabilities measured at fair value	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Interest rate cap	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate cap	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Warrants issued with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	0
Fair Value, Measurements, Recurring \| (Level 1) \| Compound embedded derivative with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	0
Fair Value, Measurements, Recurring \| (Level 1) \| Compound embedded derivative with 8.00% Notes Issued in 2013	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	0	0
Fair Value, Measurements, Recurring \| (Level 2)	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total assets measured at fair value	72	185
Total derivative liabilities, current and non-current	0	0
Liability for contingent consideration	0	0
Total liabilities measured at fair value	0	0
Fair Value, Measurements, Recurring \| (Level 2) \| Interest rate cap	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate cap	72	185
Fair Value, Measurements, Recurring \| (Level 2) \| Warrants issued with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	0
Fair Value, Measurements, Recurring \| (Level 2) \| Compound embedded derivative with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	0
Fair Value, Measurements, Recurring \| (Level 2) \| Compound embedded derivative with 8.00% Notes Issued in 2013	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	0	0
Fair Value, Measurements, Recurring \| (Level 2) \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	0	0
Fair Value, Measurements, Recurring \| (Level 3)	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total assets measured at fair value	'	'
Total derivative liabilities, current and non-current	-575,803	-462,526
Liability for contingent consideration	-1,149	-1,923
Total liabilities measured at fair value	-576,952	-464,449
Fair Value, Measurements, Recurring \| (Level 3) \| Interest rate cap	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Interest rate cap	0	0
Fair Value, Measurements, Recurring \| (Level 3) \| Warrants issued with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	-57,048
Fair Value, Measurements, Recurring \| (Level 3) \| Compound embedded derivative with 8.00% Notes Issued in 2009	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	'	-66,022
Fair Value, Measurements, Recurring \| (Level 3) \| Compound embedded derivative with 8.00% Notes Issued in 2013	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	-109,896	-109,794
Fair Value, Measurements, Recurring \| (Level 3) \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total derivative liabilities, current and non-current	($465,907)	($229,662)

Schedule_of_Significant_Quanti

Schedule of Significant Quantitative Level 3 Inputs Utilized (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Compound embedded derivative with 8.00% Notes Issued in 2013	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Risk-Free Interest Rate	1.30%	1.50%
Note Conversion Price/Warrant Exercise Price (USD per share)	$0.73	$0.73
Market Price of Common Stock	$3.66	$1.75
Compound embedded derivative with 8.00% Notes Issued in 2013 \| Minimum	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	65.00%	65.00%
Compound embedded derivative with 8.00% Notes Issued in 2013 \| Maximum	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	95.00%	100.00%
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Risk-Free Interest Rate	2.40%	3.00%
Note Conversion Price/Warrant Exercise Price (USD per share)	$0.73	$0.73
Market Price of Common Stock	$3.66	$1.75
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement \| Minimum	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	50.00%	65.00%
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement \| Maximum	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	90.00%	100.00%
Compound embedded derivative with 8.00% Notes Issued in 2009	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Risk-Free Interest Rate	'	1.50%
Note Conversion Price/Warrant Exercise Price (USD per share)	'	$1.14
Market Price of Common Stock	'	$1.75
Compound embedded derivative with 8.00% Notes Issued in 2009 \| Minimum	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	'	65.00%
Compound embedded derivative with 8.00% Notes Issued in 2009 \| Maximum	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	'	100.00%
Warrants issued with 8.00% Notes Issued in 2009	'	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]	'	'
Stock Price Volatility	'	100.00%
Risk-Free Interest Rate	'	0.10%
Note Conversion Price/Warrant Exercise Price (USD per share)	'	$0.32
Market Price of Common Stock	'	$1.75

Fair_Value_Measurements_Additi

Fair Value Measurements (Additional Information) (Details) (USD $)	9 Months Ended	1 Months Ended	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2009	Sep. 30, 2014	Sep. 30, 2014	Apr. 15, 2014	20-May-13	Jun. 30, 2009	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	20-May-13
		Axonn	Axonn	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Unsecured Notes Issued in 2009	8.00% Convertible Senior Notes Issued in 2013	8.00% Convertible Senior Notes Issued in 2013	8.00% Convertible Senior Notes Issued in 2013
								Minimum
Fair Value Measurements [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Loan interest rate	'	'	'	8.00%	'	8.00%	8.00%	'	'	8.00%	8.00%
Conversion price per share of common stock (USD per share)	'	'	'	'	$1.14	'	'	$1	$0.73	'	$0.80
Convertible debt, percentage of stock price trigger	200.00%	'	'	200.00%	'	'	'	'	'	'	'
Convertible debt, consecutive trading days threshold	'30 days	'	'	'30 days	'	'	'	'	'	'	'
Stock issuance settlement period	'40 days	'	'	'	'	'	'	'	'	'	'
Contingent consideration for earnouts	'	$10,800,000	$9,800,000	'	'	'	'	'	'	'	'
Additional earnout payment period	'	'5 years	'	'	'	'	'	'	'	'	'
Common stock, shares outstanding (shares)	'	26,684,807	'	'	'	'	'	'	'	'	'
Company outstanding common stock, percent	'	10.00%	'	'	'	'	'	'	'	'	'
Shares to be issued to exercise cash payment option for earnout payments	'	13,000,000	'	'	'	'	'	'	'	'	'
Earnout payments	'	'	8,700,000	'	'	'	'	'	'	'	'
Issuance of voting common stock shares for settlement of earnout payments	'	'	18,700,000	'	'	'	'	'	'	'	'
Fair value of contingent consideration	'	'	$1,100,000	'	'	'	'	'	'	'	'

Reconciliation_of_Assets_and_L

Reconciliation of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Beginning balance	($775,361)	($464,449)
Change in fair value of contingent consideration	-189	-809
Unrealized loss, included in derivative gain (loss)	166,996	-418,551
Ending balance	-576,952	-576,952
Guarantees	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Earnout payments made/Adjustments related to conversions and exercises	585	1,583
Derivative Financial Instruments, Liabilities	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Earnout payments made/Adjustments related to conversions and exercises	$31,017	$305,274

Accrued_Expenses_and_NonCurren2

Accrued Expenses and Non-Current Liabilities (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Accrued expenses:	'	'
Accrued interest	$5,750	$1,200
Accrued compensation and benefits	2,552	3,927
Accrued property and other taxes	5,366	5,744
Accrued customer liabilities and deposits	2,822	2,663
Accrued professional and other service provider fees	1,826	705
Accrued liability for contingent consideration	1,149	1,922
Accrued commissions	974	1,316
Accrued telecommunications expenses	918	649
Accrued second-generation constellation costs	1,887	0
Other accrued expenses	2,622	4,574
Total accrued expenses	25,866	22,700
Non-current liabilities:	'	'
Long-term accrued interest	259	451
Asset retirement obligation	1,158	1,083
Deferred rent and capital lease obligations	433	456
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,594	1,575
Uncertain income tax positions	6,704	5,918
Foreign tax contingencies	3,839	4,213
Total noncurrent liabilities	$13,987	$13,696

Commitments_Details

Commitments (Details) (USD $)

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Jul. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

31-May-14

Jun. 30, 2014

Jul. 31, 2014

Jul. 01, 2014

Qualcomm Incorporated

Hughes Network Systems LLC

Ericsson Inc.

Hughes Network Systems LLC

Commitments [Line Items]

Increase in contract amount

$3,800,000

Discount on prepayment of contract obligations made by issuance of stock

7.00%

Payments made in convertible notes and common stock

9,900,000

Loss on equity issuance

700,000

Contract amount

25,400,000

Advances for inventory

196,000

9,359,000

2,000,000

9,200,000

Payments to take ownership of inventory

-4,403,000

-4,253,000

100,000

Cost of subscriber equipment sales - reduction in the value of inventory

$7,317,000

$7,300,000

Contingencies_Details

Contingencies (Details) (Thales Alenia Space, EUR €)	0 Months Ended			3 Months Ended	12 Months Ended
	Jun. 24, 2012	10-May-12	Jun. 03, 2011	Sep. 30, 2013	Dec. 31, 2013
	Jun. 24, 2012	10-May-12	satellite	Sep. 30, 2013	Dec. 31, 2013
Thales Alenia Space	'	'	'	'	'
Loss Contingencies [Line Items]	'	'	'	'	'
Number of second-generation satellites (in satellites)	'	'	25	'	'
Contract termination, damages awarded	'	€ 51,330,875	'	'	'
Contract termination charge	'	53,000,000	'	17,500,000	'
Gain on release of liability	35,623,770	'	'	'	'
Settlement amount	'	'	'	'	€ 17,530,000

Related_Party_Transactions_Add

Related Party Transactions (Additional Information) (Details) (USD $)

0 Months Ended

1 Months Ended

3 Months Ended

4 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

13 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

Dec. 27, 2013

Oct. 14, 2013

20-May-13

21-May-13

Oct. 31, 2013

Jun. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2013

Nov. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Aug. 31, 2014

Jun. 30, 2014

Sep. 30, 2013

Jul. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

20-May-13

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

20-May-13

Jun. 30, 2009

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Oct. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2011

Jun. 30, 2009

Nonvoting Common Stock

Thermo Loan Agreement

8.00% Convertible Senior Notes Issued in 2013

Thermo Loan Agreement

Contingent Equity Agreement

8.00% Convertible Senior Unsecured Notes Issued in 2009

5.00% Convertible Senior Unsecured Notes

Thermo Capital Partners LLC

5.00% Convertible Senior Unsecured Notes

8.00% Convertible Senior Unsecured Notes Issued in 2009

Thermo Loan Agreement

Related Party Transaction [Line Items]

Payables to Thermo and other affiliates

$400,000

$200,000

Deposit to contingent equity account

60,000,000

Notes purchased by related party

20,000,000

11,400,000

Loan interest rate

8.00%

5.00%

12.00%

Short-term loan converted into nonvoting common stock

2,300,000

Maximum borrowing capacity

55,000,000

37,500,000

25,000,000

Loss on equity issuance

-2,733,000

-16,701,000

-2,404,000

-16,373,000

-16,400,000

Interest rate, payable in cash

5.75%

Proceeds from contingent equity agreement

1,100,000

1,071,000

Number of shares issued per option agreement (in shares)

26,000,000

11,538,461

38,461,538

2,133,656

Discount on shares

0.00%

Fair value of debt

120,100,000

Loss on extinguishment of debt

($12,936,000)

($63,569,000)

($47,200,000)

($39,615,000)

($110,809,000)

($66,100,000)

($43,800,000)

$4,300,000

($66,088,000)

Number of warrants exercised (in warrants)

4,400,000

16,300,000

4,200,000

Number of shares issued (in shares)

78,125,000

15,625,000

28,125,000

121,900,000

171,900,000

14,700,000

4,400,000

4,200,000

Warrants outstanding (warrants)

45,088,418

93,516,401

[1]

4,205,608

[1]

37,088,418

[2]

41,467,980

[2]

[3]

39,842,813

[3]

15,300,000

8,000,000

[4]

8,000,000

[4]

Number of shares of non-voting common stock converted (shares)

75,000,000

[1]

[2]

[3]

The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014. All 8.00% Warrants were exercised in the second quarter of 2014.

[4]

The 5.0% Warrants are exercisable until June 2016, which is five years after their issuance.

Expense_Incurred_on_Behalf_of_

Expense Incurred on Behalf of Company (Details) (USD $)	3 Months Ended			9 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Thermo Capital Partners LLC	Thermo Capital Partners LLC	Thermo Capital Partners LLC	Thermo Capital Partners LLC	Thermo Capital Partners LLC
Related Party Transaction [Line Items]	'	'	'	'	'	'	'	'	'	'
General and administrative expenses	'	'	'	'	'	$174	$74	$236	$229	'
Non-cash expenses	'	'	'	0	16,701	137	137	411	411	'
Loss on equity issuance	0	2,733	'	0	16,701	0	2,404	0	16,373	16,400
Loss on extinguishment of debt	12,936	63,569	47,200	39,615	110,809	0	66,088	0	66,088	'
Total	'	'	'	'	'	$311	$68,703	$647	$83,101	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Income Tax Contingency [Line Items]	'	'
Undistributed earnings from certain foreign subsidiaries	$12.20	'
Foreign Tax Authority	'	'
Income Tax Contingency [Line Items]	'	'
Tax liability	$2.10	$2.20

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'	'	'
Accumulated other comprehensive loss, beginning balance	$493	($2,408)	$871	($1,758)
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation adjustments	-493	553	-871	-97
Accumulated other comprehensive loss, ending balance	$0	($1,855)	$0	($1,855)

Stock_Compensation_Stock_Compe

Stock Compensation Stock Compensation Expense (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Stock-based compensation expense	$1.10	$1	$2.10	$1.70
Employee Stock Option	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Share price triggering vesting (USD per share)	'	$0.80	'	'
Accelerated compensation cost	'	$0.80	'	'

Grants_to_Eligible_Participant

Grants to Eligible Participants of Incentive Stock Options, Restricted Stock Awards and Restricted Stock Units (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'	'	'
Grants of restricted stock awards and restricted stock units (in shares)	201	14	607	852
Grants of options to purchase common stock (in shares)	134	1,224	595	1,829
Total (in shares)	335	1,238	1,202	2,681

Stock_Based_Compensation_Addit

Stock Based Compensation (Additional Information) (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'	'	'	'
Stock-based compensation expense	$1,100,000	$1,000,000	$2,100,000	$1,700,000
Employee Stock Purchase Plan	'	'	'	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'	'	'	'
Percentage of share that can be purchased by eligible employees to their total compensation	15.00%	'	15.00%	'
Maximum value of shares that can be purchased by eligible employee	'	'	25,000	'
Maximum number of shares that can be purchased by eligible employee	'	'	500,000	'
Percentage of fair market value of common stock payed by employee	'	'	85.00%	'
Stock-based compensation expense	'	'	$100,000	$200,000
Company issued shares related to this stock purchase plan	'	'	2,486,902	'

Information_by_Geographic_Area

Information by Geographic Area Revenues (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting Information [Line Items]	'	'	'	'
Service revenues	$18,511	$17,056	$52,647	$47,854
Subscriber equipment revenues	4,930	5,493	15,324	13,863
Total revenue	23,441	22,549	67,971	61,717
United States	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenues	12,267	11,660	35,000	33,666
Subscriber equipment revenues	2,510	3,688	8,340	8,756
Canada	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenues	4,077	3,446	10,946	9,123
Subscriber equipment revenues	1,418	1,201	4,187	2,964
Europe	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenues	1,655	1,185	4,407	2,736
Subscriber equipment revenues	540	327	1,628	1,228
Central and South America	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenues	440	625	1,886	1,918
Subscriber equipment revenues	437	177	930	712
Others	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Service revenues	72	140	408	411
Subscriber equipment revenues	$25	$100	$239	$203

Information_by_Geographic_Area1

Information by Geographic Area, Long-Lived Assets (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Segment Reporting, Asset Reconciling Item [Line Items]	'	'
Property and equipment, net	$1,120,156	$1,169,785
United States	'	'
Segment Reporting, Asset Reconciling Item [Line Items]	'	'
Property and equipment, net	1,114,934	1,164,358
Canada	'	'
Segment Reporting, Asset Reconciling Item [Line Items]	'	'
Property and equipment, net	318	247
Europe	'	'
Segment Reporting, Asset Reconciling Item [Line Items]	'	'
Property and equipment, net	470	408
Central and South America	'	'
Segment Reporting, Asset Reconciling Item [Line Items]	'	'
Property and equipment, net	3,510	3,595
Others	'	'
Segment Reporting, Asset Reconciling Item [Line Items]	'	'
Property and equipment, net	$924	$1,177

Earning_Loss_Per_Share_Details

Earning (Loss) Per Share (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Basic (shares)	987,668	673,546	914,474	559,515
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	7,340	'	'	'
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants	45,088	'	'	'
Diluted (shares)	1,189,190	673,546	914,474	559,515
Conversions Of 8 Percent Notes Issued In 2013 [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	39,625	'	'	'
Thermo Loan Agreement	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	109,469	'	'	'

Supplemental_Condensed_Consoli2

Supplemental Condensed Consolidating Statement of Operations (Details) (USD $)	3 Months Ended			9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue:	'	'	'	'	'
Service revenues	$18,511	$17,056	'	$52,647	$47,854
Subscriber equipment sales	4,930	5,493	'	15,324	13,863
Total revenue	23,441	22,549	'	67,971	61,717
Operating expenses:	'	'	'	'	'
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	7,868	8,181	'	21,926	22,913
Cost of subscriber equipment sales	3,836	4,148	'	11,240	10,675
Cost of subscriber equipment sales - reduction in the value of inventory	0	0	'	7,317	0
Marketing, general, and administrative	8,783	9,079	'	24,799	22,579
Depreciation, amortization, and accretion	21,047	23,715	'	66,393	66,114
Total operating expenses	41,534	45,123	'	131,675	122,281
Loss from operations	-18,093	-22,574	'	-63,704	-60,564
Other income (expense):	'	'	'	'	'
Loss on extinguishment of debt	-12,936	-63,569	-47,200	-39,615	-110,809
Loss on equity issuance	0	-2,733	'	0	-16,701
Interest income and expense, net of amounts capitalized	-9,067	-16,901	'	-33,853	-39,869
Derivative gain (loss)	166,989	-97,534	'	-418,663	-126,911
Equity in subsidiary earnings	0	0	'	0	0
Other	2,586	-1,540	'	2,207	-1,125
Total other income (expense)	147,572	-182,277	'	-489,924	-295,415
Income (loss) before income taxes	129,479	-204,851	'	-553,628	-355,979
Income tax expense	89	118	'	1,255	341
Net income (loss)	129,390	-204,969	'	-554,883	-356,320
Comprehensive (loss) income	128,896	-204,417	'	-555,754	-356,417
Reportable Legal Entities \| Parent Company	'	'	'	'	'
Revenue:	'	'	'	'	'
Service revenues	19,258	18,726	'	56,627	50,351
Subscriber equipment sales	71	127	'	387	287
Total revenue	19,329	18,853	'	57,014	50,638
Operating expenses:	'	'	'	'	'
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	2,903	3,125	'	7,958	8,233
Cost of subscriber equipment sales	31	90	'	243	90
Cost of subscriber equipment sales - reduction in the value of inventory	0	'	'	7,258	'
Marketing, general, and administrative	1,906	2,008	'	5,501	4,555
Depreciation, amortization, and accretion	19,180	19,645	'	57,636	52,538
Total operating expenses	24,020	24,868	'	78,596	65,416
Loss from operations	-4,691	-6,015	'	-21,582	-14,778
Other income (expense):	'	'	'	'	'
Loss on extinguishment of debt	-12,936	-63,569	'	-39,615	-110,809
Loss on equity issuance	'	-2,733	'	'	-16,701
Interest income and expense, net of amounts capitalized	-9,001	-16,636	'	-33,598	-38,728
Derivative gain (loss)	166,989	-97,534	'	-418,663	-126,911
Equity in subsidiary earnings	-12,653	-17,090	'	-42,471	-47,313
Other	1,782	-1,343	'	1,250	-909
Total other income (expense)	134,181	-198,905	'	-533,097	-341,371
Income (loss) before income taxes	129,490	-204,920	'	-554,679	-356,149
Income tax expense	100	49	'	204	171
Net income (loss)	129,390	-204,969	'	-554,883	-356,320
Comprehensive (loss) income	129,390	-204,969	'	-554,883	-356,320
Reportable Legal Entities \| Guarantor Subsidiaries	'	'	'	'	'
Revenue:	'	'	'	'	'
Service revenues	1,494	2,478	'	4,859	8,544
Subscriber equipment sales	3,471	4,254	'	10,966	10,018
Total revenue	4,965	6,732	'	15,825	18,562
Operating expenses:	'	'	'	'	'
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	2,653	3,126	'	7,101	7,947
Cost of subscriber equipment sales	2,962	3,334	'	8,578	8,048
Cost of subscriber equipment sales - reduction in the value of inventory	0	'	'	19	'
Marketing, general, and administrative	3,850	4,666	'	11,994	11,710
Depreciation, amortization, and accretion	1,879	4,914	'	9,589	15,936
Total operating expenses	11,344	16,040	'	37,281	43,641
Loss from operations	-6,379	-9,308	'	-21,456	-25,079
Other income (expense):	'	'	'	'	'
Loss on extinguishment of debt	'	'	'	0	0
Loss on equity issuance	'	0	'	'	0
Interest income and expense, net of amounts capitalized	-10	-3	'	-30	-39
Derivative gain (loss)	'	'	'	0	0
Equity in subsidiary earnings	-884	-1,729	'	-5,100	-2,794
Other	409	-171	'	400	-170
Total other income (expense)	-485	-1,903	'	-4,730	-3,003
Income (loss) before income taxes	-6,864	-11,211	'	-26,186	-28,082
Income tax expense	7	6	'	34	35
Net income (loss)	-6,871	-11,217	'	-26,220	-28,117
Comprehensive (loss) income	-6,871	-11,217	'	-26,220	-28,117
Reportable Legal Entities \| Non- Guarantor Subsidiaries	'	'	'	'	'
Revenue:	'	'	'	'	'
Service revenues	6,389	4,940	'	17,279	13,320
Subscriber equipment sales	5,118	1,070	'	9,271	13,264
Total revenue	11,507	6,010	'	26,550	26,584
Operating expenses:	'	'	'	'	'
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	2,563	1,941	'	7,289	6,791
Cost of subscriber equipment sales	4,823	1,819	'	9,415	14,323
Cost of subscriber equipment sales - reduction in the value of inventory	0	'	'	40	'
Marketing, general, and administrative	4,408	3,774	'	10,910	9,895
Depreciation, amortization, and accretion	6,974	6,485	'	20,113	17,167
Total operating expenses	18,768	14,019	'	47,767	48,176
Loss from operations	-7,261	-8,009	'	-21,217	-21,592
Other income (expense):	'	'	'	'	'
Loss on extinguishment of debt	'	'	'	0	0
Loss on equity issuance	'	0	'	'	0
Interest income and expense, net of amounts capitalized	-57	-262	'	-226	-1,098
Derivative gain (loss)	'	'	'	0	0
Equity in subsidiary earnings	'	'	'	0	0
Other	364	-21	'	643	-124
Total other income (expense)	307	-283	'	417	-1,222
Income (loss) before income taxes	-6,954	-8,292	'	-20,800	-22,814
Income tax expense	-18	63	'	1,017	135
Net income (loss)	-6,936	-8,355	'	-21,817	-22,949
Comprehensive (loss) income	-7,430	-7,803	'	-22,688	-23,046
Eliminations	'	'	'	'	'
Revenue:	'	'	'	'	'
Service revenues	-8,630	-9,088	'	-26,118	-24,361
Subscriber equipment sales	-3,730	42	'	-5,300	-9,706
Total revenue	-12,360	-9,046	'	-31,418	-34,067
Operating expenses:	'	'	'	'	'
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	-251	-11	'	-422	-58
Cost of subscriber equipment sales	-3,980	-1,095	'	-6,996	-11,786
Cost of subscriber equipment sales - reduction in the value of inventory	0	'	'	0	'
Marketing, general, and administrative	-1,381	-1,369	'	-3,606	-3,581
Depreciation, amortization, and accretion	-6,986	-7,329	'	-20,945	-19,527
Total operating expenses	-12,598	-9,804	'	-31,969	-34,952
Loss from operations	238	758	'	551	885
Other income (expense):	'	'	'	'	'
Loss on extinguishment of debt	'	'	'	0	0
Loss on equity issuance	'	0	'	'	0
Interest income and expense, net of amounts capitalized	1	'	'	1	-4
Derivative gain (loss)	'	'	'	0	0
Equity in subsidiary earnings	13,537	18,819	'	47,571	50,107
Other	31	-5	'	-86	78
Total other income (expense)	13,569	18,814	'	47,486	50,181
Income (loss) before income taxes	13,807	19,572	'	48,037	51,066
Income tax expense	'	'	'	0	0
Net income (loss)	13,807	19,572	'	48,037	51,066
Comprehensive (loss) income	$13,807	$19,572	'	$48,037	$51,066

Supplemental_Condensed_Consoli3

Supplemental Condensed Consolidating Balance Sheet (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
Current assets:	'	'	'	'
Cash and cash equivalents	$27,221	$17,408	$6,643	$11,792
Accounts receivable	16,217	15,723	'	'
Intercompany receivables	0	0	'	'
Inventory	29,277	31,817	'	'
Advances for inventory	196	9,359	'	'
Prepaid expenses and other current assets	7,456	7,059	'	'
Total current assets	80,367	81,366	'	'
Property and equipment, net	1,120,156	1,169,785	'	'
Restricted cash	37,918	37,918	'	'
Intercompany notes receivable	0	0	'	'
Investment in subsidiaries	0	0	'	'
Deferred financing costs	66,816	76,436	'	'
Intangible and other assets, net of accumulated amortization of $6,138 and $5,669, respectively	14,703	7,103	'	'
Total assets	1,319,960	1,372,608	'	'
Current liabilities:	'	'	'	'
Current portion of long-term debt	7,271	4,046	'	'
Accounts payable	12,195	14,627	'	'
Accrued contract termination charge	22,238	24,133	'	'
Accrued expenses	25,866	22,700	'	'
Intercompany payables	0	0	'	'
Payables to affiliates	443	202	'	'
Derivative liabilities	0	57,048	'	'
Deferred revenue	22,191	17,284	'	'
Total current liabilities	90,204	140,040	'	'
Long-term debt, less current portion	623,770	665,236	'	'
Employee benefit obligations	3,146	3,529	'	'
Intercompany notes payable	0	0	'	'
Derivative liabilities	575,803	405,478	'	'
Deferred revenue	6,787	7,079	'	'
Debt restructuring fees	20,795	20,795	'	'
Other non-current liabilities	13,987	13,696	'	'
Total non-current liabilities	1,244,288	1,115,813	'	'
Total stockholdersb (deficit) equity	-14,532	116,755	'	'
Total liabilities and stockholdersb (deficit) equity	1,319,960	1,372,608	'	'
Reportable Legal Entities \| Parent Company	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	22,921	12,935	4,298	10,220
Accounts receivable	4,582	5,925	'	'
Intercompany receivables	727,100	651,251	'	'
Inventory	4,122	1,161	'	'
Advances for inventory	125	9,287	'	'
Prepaid expenses and other current assets	4,374	4,316	'	'
Total current assets	763,224	684,875	'	'
Property and equipment, net	1,111,237	1,152,734	'	'
Restricted cash	37,918	37,918	'	'
Intercompany notes receivable	13,006	13,629	'	'
Investment in subsidiaries	-241,579	-209,592	'	'
Deferred financing costs	66,816	76,436	'	'
Intangible and other assets, net of accumulated amortization of $6,138 and $5,669, respectively	11,999	3,964	'	'
Total assets	1,762,621	1,759,964	'	'
Current liabilities:	'	'	'	'
Current portion of long-term debt	7,271	4,046	'	'
Accounts payable	8,112	9,906	'	'
Accrued contract termination charge	22,238	24,133	'	'
Accrued expenses	11,122	6,160	'	'
Intercompany payables	492,868	435,707	'	'
Payables to affiliates	443	202	'	'
Derivative liabilities	'	57,048	'	'
Deferred revenue	2,885	1,843	'	'
Total current liabilities	544,939	539,045	'	'
Long-term debt, less current portion	623,770	665,236	'	'
Employee benefit obligations	3,147	3,529	'	'
Intercompany notes payable	'	'	'	'
Derivative liabilities	575,803	405,478	'	'
Deferred revenue	6,330	6,583	'	'
Debt restructuring fees	20,795	20,795	'	'
Other non-current liabilities	2,369	2,543	'	'
Total non-current liabilities	1,232,214	1,104,164	'	'
Total stockholdersb (deficit) equity	-14,532	116,755	'	'
Total liabilities and stockholdersb (deficit) equity	1,762,621	1,759,964	'	'
Reportable Legal Entities \| Guarantor Subsidiaries	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	912	676	359	251
Accounts receivable	6,151	5,022	'	'
Intercompany receivables	436,281	414,508	'	'
Inventory	12,419	14,375	'	'
Advances for inventory	28	28	'	'
Prepaid expenses and other current assets	278	311	'	'
Total current assets	456,069	434,920	'	'
Property and equipment, net	3,697	11,621	'	'
Restricted cash	'	'	'	'
Intercompany notes receivable	'	'	'	'
Investment in subsidiaries	4,216	7,242	'	'
Deferred financing costs	'	'	'	'
Intangible and other assets, net of accumulated amortization of $6,138 and $5,669, respectively	671	1,028	'	'
Total assets	464,653	454,811	'	'
Current liabilities:	'	'	'	'
Current portion of long-term debt	'	'	'	'
Accounts payable	2,045	2,041	'	'
Accrued contract termination charge	'	'	'	'
Accrued expenses	7,195	8,203	'	'
Intercompany payables	552,218	521,763	'	'
Payables to affiliates	'	'	'	'
Derivative liabilities	'	'	'	'
Deferred revenue	16,092	13,094	'	'
Total current liabilities	577,550	545,101	'	'
Long-term debt, less current portion	'	'	'	'
Employee benefit obligations	'	'	'	'
Intercompany notes payable	'	'	'	'
Derivative liabilities	'	'	'	'
Deferred revenue	457	496	'	'
Debt restructuring fees	'	'	'	'
Other non-current liabilities	293	297	'	'
Total non-current liabilities	750	793	'	'
Total stockholdersb (deficit) equity	-113,647	-91,083	'	'
Total liabilities and stockholdersb (deficit) equity	464,653	454,811	'	'
Reportable Legal Entities \| Non- Guarantor Subsidiaries	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	3,388	3,797	1,986	1,321
Accounts receivable	5,227	4,602	'	'
Intercompany receivables	23,711	18,280	'	'
Inventory	12,736	16,281	'	'
Advances for inventory	43	44	'	'
Prepaid expenses and other current assets	2,804	2,432	'	'
Total current assets	47,909	45,436	'	'
Property and equipment, net	6,277	6,889	'	'
Restricted cash	'	'	'	'
Intercompany notes receivable	4,885	4,285	'	'
Investment in subsidiaries	29,382	'	'	'
Deferred financing costs	'	'	'	'
Intangible and other assets, net of accumulated amortization of $6,138 and $5,669, respectively	2,047	2,125	'	'
Total assets	90,500	58,735	'	'
Current liabilities:	'	'	'	'
Current portion of long-term debt	'	'	'	'
Accounts payable	2,038	2,680	'	'
Accrued contract termination charge	'	'	'	'
Accrued expenses	7,549	8,337	'	'
Intercompany payables	144,152	128,496	'	'
Payables to affiliates	'	'	'	'
Derivative liabilities	'	'	'	'
Deferred revenue	3,214	2,347	'	'
Total current liabilities	156,953	141,860	'	'
Long-term debt, less current portion	'	'	'	'
Employee benefit obligations	-1	'	'	'
Intercompany notes payable	15,448	15,772	'	'
Derivative liabilities	'	'	'	'
Deferred revenue	'	0	'	'
Debt restructuring fees	'	'	'	'
Other non-current liabilities	11,325	10,856	'	'
Total non-current liabilities	26,772	26,628	'	'
Total stockholdersb (deficit) equity	-93,225	-109,753	'	'
Total liabilities and stockholdersb (deficit) equity	90,500	58,735	'	'
Eliminations	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	'	'	'
Accounts receivable	257	174	'	'
Intercompany receivables	-1,187,092	-1,084,039	'	'
Inventory	'	'	'	'
Advances for inventory	'	'	'	'
Prepaid expenses and other current assets	'	'	'	'
Total current assets	-1,186,835	-1,083,865	'	'
Property and equipment, net	-1,055	-1,459	'	'
Restricted cash	'	'	'	'
Intercompany notes receivable	-17,891	-17,914	'	'
Investment in subsidiaries	207,981	202,350	'	'
Deferred financing costs	'	'	'	'
Intangible and other assets, net of accumulated amortization of $6,138 and $5,669, respectively	-14	-14	'	'
Total assets	-997,814	-900,902	'	'
Current liabilities:	'	'	'	'
Current portion of long-term debt	'	'	'	'
Accounts payable	'	'	'	'
Accrued contract termination charge	'	'	'	'
Accrued expenses	'	'	'	'
Intercompany payables	-1,189,238	-1,085,966	'	'
Payables to affiliates	'	'	'	'
Derivative liabilities	'	'	'	'
Deferred revenue	'	'	'	'
Total current liabilities	-1,189,238	-1,085,966	'	'
Long-term debt, less current portion	'	'	'	'
Employee benefit obligations	'	'	'	'
Intercompany notes payable	-15,448	-15,772	'	'
Derivative liabilities	'	'	'	'
Deferred revenue	'	0	'	'
Debt restructuring fees	'	'	'	'
Other non-current liabilities	0	'	'	'
Total non-current liabilities	-15,448	-15,772	'	'
Total stockholdersb (deficit) equity	206,872	200,836	'	'
Total liabilities and stockholdersb (deficit) equity	($997,814)	($900,902)	'	'

Supplemental_Condensed_Consoli4

Supplemental Condensed Consolidating Statement of Cash Flows (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by (used in) operating activities	$6,875	$2,334
Cash flows from investing activities:	'	'
Second-generation satellites, ground and related launch costs	-3,862	-37,732
Property and equipment additions	-2,203	-1,225
Investment in business	0	-496
Restricted cash	0	8,838
Net cash used in investing activities	-6,065	-30,615
Cash flows provided by (used in) financing activities	'	'
Borrowings from Facility Agreement	0	672
Proceeds from contingent equity agreement	0	1,071
Proceeds from issuance of common stock and stock options	9,303	8,979
Payment of deferred financing costs	-164	-16,904
Payments to reduce principal amount of exchanged 5.75% Notes	0	-13,544
Payments to reduce principal amount of 5.75% Notes not exchanged	0	-6,250
Payments to lenders and other fees associated with exchange	0	-2,482
Proceeds from equity issuance to related party	0	51,500
Net cash provided by financing activities	9,139	23,042
Effect of exchange rate changes on cash and cash equivalents	-136	90
Net increase (decrease) in cash and cash equivalents	9,813	-5,149
Cash and cash equivalents, beginning of period	17,408	11,792
Cash and cash equivalents, end of period	27,221	6,643
Reportable Legal Entities \| Parent Company	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by (used in) operating activities	6,066	426
Cash flows from investing activities:	'	'
Second-generation satellites, ground and related launch costs	-3,862	-37,732
Property and equipment additions	-1,357	'
Investment in business	'	-496
Restricted cash	'	8,838
Net cash used in investing activities	-5,219	-29,390
Cash flows provided by (used in) financing activities	'	'
Borrowings from Facility Agreement	'	672
Proceeds from contingent equity agreement	'	1,071
Proceeds from issuance of common stock and stock options	9,303	8,979
Payment of deferred financing costs	-164	-16,904
Payments to reduce principal amount of exchanged 5.75% Notes	'	-13,544
Payments to reduce principal amount of 5.75% Notes not exchanged	'	-6,250
Payments to lenders and other fees associated with exchange	'	-2,482
Proceeds from equity issuance to related party	'	51,500
Net cash provided by financing activities	9,139	23,042
Effect of exchange rate changes on cash and cash equivalents	'	'
Net increase (decrease) in cash and cash equivalents	9,986	-5,922
Cash and cash equivalents, beginning of period	12,935	10,220
Cash and cash equivalents, end of period	22,921	4,298
Reportable Legal Entities \| Guarantor Subsidiaries	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by (used in) operating activities	728	814
Cash flows from investing activities:	'	'
Second-generation satellites, ground and related launch costs	'	'
Property and equipment additions	-492	-706
Investment in business	'	0
Restricted cash	'	'
Net cash used in investing activities	-492	-706
Cash flows provided by (used in) financing activities	'	'
Proceeds from issuance of common stock and stock options	'	0
Payment of deferred financing costs	'	'
Payments to reduce principal amount of exchanged 5.75% Notes	'	0
Payments to reduce principal amount of 5.75% Notes not exchanged	'	0
Payments to lenders and other fees associated with exchange	'	0
Proceeds from equity issuance to related party	'	0
Net cash provided by financing activities	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'
Net increase (decrease) in cash and cash equivalents	236	108
Cash and cash equivalents, beginning of period	676	251
Cash and cash equivalents, end of period	912	359
Reportable Legal Entities \| Non- Guarantor Subsidiaries	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by (used in) operating activities	81	1,094
Cash flows from investing activities:	'	'
Second-generation satellites, ground and related launch costs	'	'
Property and equipment additions	-354	-519
Investment in business	'	0
Restricted cash	'	'
Net cash used in investing activities	-354	-519
Cash flows provided by (used in) financing activities	'	'
Proceeds from issuance of common stock and stock options	'	0
Payment of deferred financing costs	'	'
Payments to reduce principal amount of exchanged 5.75% Notes	'	0
Payments to reduce principal amount of 5.75% Notes not exchanged	'	0
Payments to lenders and other fees associated with exchange	'	0
Proceeds from equity issuance to related party	'	0
Net cash provided by financing activities	'	'
Effect of exchange rate changes on cash and cash equivalents	-136	90
Net increase (decrease) in cash and cash equivalents	-409	665
Cash and cash equivalents, beginning of period	3,797	1,321
Cash and cash equivalents, end of period	3,388	1,986
Eliminations	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by (used in) operating activities	'	'
Cash flows from investing activities:	'	'
Second-generation satellites, ground and related launch costs	'	'
Property and equipment additions	'	'
Investment in business	'	0
Restricted cash	'	'
Net cash used in investing activities	'	'
Cash flows provided by (used in) financing activities	'	'
Proceeds from issuance of common stock and stock options	'	0
Payment of deferred financing costs	'	'
Payments to reduce principal amount of exchanged 5.75% Notes	'	0
Payments to reduce principal amount of 5.75% Notes not exchanged	'	0
Payments to lenders and other fees associated with exchange	'	0
Proceeds from equity issuance to related party	'	0
Net cash provided by financing activities	'	'
Effect of exchange rate changes on cash and cash equivalents	'	'
Net increase (decrease) in cash and cash equivalents	'	'
Cash and cash equivalents, beginning of period	'	'
Cash and cash equivalents, end of period	'	'